JP2014003960A - Liquid nutritive composition - Google Patents

Liquid nutritive composition Download PDF

Info

Publication number
JP2014003960A
JP2014003960A JP2012143928A JP2012143928A JP2014003960A JP 2014003960 A JP2014003960 A JP 2014003960A JP 2012143928 A JP2012143928 A JP 2012143928A JP 2012143928 A JP2012143928 A JP 2012143928A JP 2014003960 A JP2014003960 A JP 2014003960A
Authority
JP
Japan
Prior art keywords
fatty acid
mass
acid
protein
emulsifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012143928A
Other languages
Japanese (ja)
Other versions
JP6098047B2 (en
Inventor
Tomoya Isaji
知也 伊佐治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Priority to JP2012143928A priority Critical patent/JP6098047B2/en
Priority to CN201310253523.2A priority patent/CN103504293B/en
Publication of JP2014003960A publication Critical patent/JP2014003960A/en
Application granted granted Critical
Publication of JP6098047B2 publication Critical patent/JP6098047B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a liquid composition having satisfactory tube flowability and bacteriostatic properties while having a high calorific value, and further to provide a liquid nutritive composition which has high emulsion stability and preferably a low osmotic pressure and can be stored for a long period of time.SOLUTION: There is provided a liquid nutritive composition which contains a protein, a carbohydrate, an emulsifier, oils and fats, and water, wherein the blending amount of the protein (A) is 2 to 11 mass%, the blending amount of the carbohydrate (B) is 10 to 35 mass%, the total blending amount of the emulsifier (C) and the oils and fats is 1 to 13 mass%. The liquid nutritive composition comprises: at least collagen peptide and vegetable peptide having a weight average molecular weight of 1000 to 5000 as the protein (A); at least a decomposed product of starch having a number average molecular weight of 400 to 900 as the carbohydrate (B); at least (i) a polyglycerol fatty acid ester in which an average degree of polymerization of polyglycerol is 6 to 20 and the main fatty acid is oleic acid and/or myristic acid and (ii) a monoglyceride in which the main fatty acid is a saturated fatty acid having 12 to 22 carbon atoms as the emulsifier (C); and at least oils and fats having a melting point of -30°C to 45°C as the oils and fats (D), and has a pH of 2.0 to 5.0.

Description

本発明は、濃厚流動食、経腸栄養剤、総合栄養食、医療食などに好適に用いることができる液状栄養組成物に関する。より詳しくは蛋白質、糖質、乳化剤、油脂、及び水を含み、pHが2.0〜5.0である液状栄養組成物に関する。   The present invention relates to a liquid nutritional composition that can be suitably used for concentrated liquid foods, enteral nutrients, comprehensive nutritional foods, medical foods, and the like. More specifically, the present invention relates to a liquid nutritional composition containing protein, saccharide, emulsifier, oil and fat, and water and having a pH of 2.0 to 5.0.

栄養補給の場において、消化管の機能は充分でありながら食物の嚥下が困難である場合には、チューブを通して栄養成分を胃または腸に投与する経腸栄養法が従来からとられている。経腸栄養法は、自然的な栄養補給方法に近いため、腸管無活動状態がもたらす腸管粘膜の廃用性萎縮や感染症等の合併症を回避できる点で、望ましい栄養補給方法であるといえる。経腸栄養法に使用される流動食においては、単位体積あたりの熱量が1.0kcal/ml程度の比較的低い流動食から、1.5kcal/ml程度以上の高熱量流動食が求められるようになってきている。高熱量流動食は、投与時間を短縮できるだけでなく、胃への容量負担を軽減して、肺炎を招く胃食道逆流の誘発リスクを軽減できるという利点がある。さらには、単位容積当たりに含まれる水が少ないため、摂取水分を制限する必要がある患者にも利便性が高いなど、付加価値の高い流動食とされている。流動食は、細いチューブを通して投与される場合が多い。そのため栄養成分の不可逆的な分離(クリーミング、沈澱)や凝集物の無いことはもとより、粘度が低い液性が求められている。高熱量流動食においては、水分含有量が少なく栄養成分含有量がおおくなるため、粘度を充分低くとどめながら、液性が均質である製品は達成されていなかった。   In the place of nutritional supplementation, enteral nutrition has been conventionally employed in which, when the function of the digestive tract is sufficient but it is difficult to swallow food, nutritional components are administered to the stomach or intestine through a tube. Since enteral nutrition is close to natural nutrition, it can be said to be a desirable nutritional supplement because it can avoid complications such as disuse atrophy of the intestinal mucosa and infection caused by intestinal inactivity. . In the liquid food used for enteral nutrition, a high-calorie liquid food of about 1.5 kcal / ml or more is required from a relatively low liquid food of about 1.0 kcal / ml per unit volume. It has become to. The high-calorie liquid diet not only shortens the administration time, but also has the advantage of reducing the risk of gastroesophageal reflux leading to pneumonia by reducing the volume burden on the stomach. Furthermore, since the amount of water contained per unit volume is small, it is a liquid food with high added value, such as high convenience for patients who need to limit the amount of water intake. Liquid food is often administered through a thin tube. Therefore, liquidity with low viscosity is required as well as irreversible separation (creaming and precipitation) of nutrient components and absence of aggregates. In the high-calorie liquid food, since the water content is small and the nutrient content is large, a product having a uniform liquidity while keeping the viscosity sufficiently low has not been achieved.

加えて、細いチューブを流下できる粘度であっても、胃酸が逆流することによって流動食中の蛋白質成分などが酸凝集し、チューブ閉塞を引き起こすという問題がある。一般的な流動食のほとんどは、pHが中性であり、酸と接触することにより凝集する性質の蛋白質を含んでいて耐酸性が無いため、このようなチューブ閉塞が少なからず発生し、チューブを一度体内から引き抜き、閉塞物を取り除き、再挿入する必要性が生じ、看護や介護をする人たちへの多大な労力を強いていた。   In addition, there is a problem that even when the viscosity is such that the thin tube can flow down, protein components and the like in the liquid food agglomerate due to backflow of gastric acid, causing tube blockage. Most common liquid foods have a neutral pH, contain proteins that aggregate when contacted with acid, and have no acid resistance. Once it was pulled out of the body, it was necessary to remove the obstruction and reinsert it, which forced a great deal of effort on the caregivers.

また、流動食が使用される場においては、開封された流動食を一度に全量投与せず、数時間〜数日保管される場合があったり、入院初期の患者へは、浸透圧性の下痢が発生しないよう緩慢投与を行うため、流動食が投与ボトル中に長時間放置される場合があったりする。このような場合、菌による腐敗が生じると、食中毒などの重篤なトラブルを招きかねない。よって、流動食中に酸性物質を溶解し、酸の静菌効果により菌増殖を抑制することが望まれる。しかし、前記のように現在発売されているか知られている流動食のほとんどは、pHが中性であり耐酸性が無いため、酸性物質を溶解すると蛋白質が凝集し、流動食としての機能を維持することができない。このため、酸による静菌は不可能であるのが現状である。これに対し、工場で生産される段階で流動食を酸性化しておけるならば、使用者が酸性物質を溶解する手間を省くことできる。従って、流動食自体が予め酸性であることが望ましいのである。   In addition, in the place where liquid food is used, the opened liquid food is not administered all at once and may be stored for several hours to several days, or osmotic diarrhea may occur in patients in the early hospitalization. Since slow administration is performed so as not to occur, the liquid food may be left in the administration bottle for a long time. In such a case, if rot caused by bacteria occurs, serious troubles such as food poisoning may occur. Therefore, it is desired to dissolve the acidic substance in the liquid food and suppress the bacterial growth by the bacteriostatic effect of the acid. However, as mentioned above, most liquid foods that are currently available or known have a neutral pH and no acid resistance, so when acidic substances are dissolved, proteins aggregate and maintain the function as a liquid food Can not do it. For this reason, it is the present condition that bacteriostatic by acid is impossible. On the other hand, if the liquid food can be acidified at the stage of production at the factory, it is possible to save the user from having to dissolve the acidic substance. Therefore, it is desirable that the liquid food itself is acidic in advance.

このように、高熱量でありながら、良好なチューブ流動性と静菌性の機能を備えた液状組成物を得るために、低粘度かつ耐酸性を有する液状栄養組成物が求められていた。加えて浸透圧性の下痢を抑制するため浸透圧が低いこと、及び、長期保存を可能とするため、熱殺菌を経た後においても長期にわたり乳化安定性が高いことが必要である。   Thus, in order to obtain a liquid composition having good tube fluidity and bacteriostatic properties while having a high calorific value, a liquid nutritional composition having low viscosity and acid resistance has been demanded. In addition, in order to suppress osmotic diarrhea, the osmotic pressure is low, and in order to enable long-term storage, it is necessary that the emulsification stability is high over a long period even after heat sterilization.

このような液状栄養組成物を提供するために、従来様々な工夫がなされてきた。例えば、特許文献1には、液状食品組成物等に添加するだけでチューブ内での詰まりや、輸液流速の変化を抑えることが可能なチューブ流動性改善剤、かつチューブ流動性改善剤を含む総合栄養流動食およびその製造方法に関する技術が開示されている。しかし、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エステルなど、チューブ内壁への液状栄養組成物の付着を防ぐ目的で添加されるチューブ流動性改善剤を配合するだけでは、耐酸性を得ることはできないため、胃酸の逆流によるチューブ閉塞や酸性物質による静菌性を得ることはできない。また、粘度を低くすること、浸透圧を低くすること、長期保存を含めた乳化安定性を良好に保つこともできない。   In order to provide such a liquid nutritional composition, various devices have been conventionally made. For example, Patent Document 1 includes a tube fluidity improver and tube fluidity improver that can suppress clogging in a tube or change in infusion flow rate by simply adding it to a liquid food composition or the like. Techniques relating to a nutrient liquid food and a method for producing the same are disclosed. However, simply adding a tube fluidity improver such as polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, etc. added for the purpose of preventing the attachment of the liquid nutritional composition to the inner wall of the tube will lead to acid resistance. Therefore, tube obstruction due to gas acid reflux and bacteriostatic properties due to acidic substances cannot be obtained. In addition, it is impossible to reduce the viscosity, to lower the osmotic pressure, and to maintain good emulsification stability including long-term storage.

特許文献2には、抗菌性を有し、発酵乳製品を用いて調製され、pH4.6以下である抗菌性を有する酸性流動食に関する技術が開示されている。しかし、この発明のように発酵乳製品を原料としpHを4.6の酸性流動食を調製するのみでは、胃酸の逆流によるチューブ閉塞や酸性物質による静菌性を得ることができても、低い粘度とすること、及び長期保存を含めた乳化安定性を良好に保つことは困難である。特に高熱量流動食とした場合は、粘度が高くなり、長期保存した場合の乳化安定性が保てなくなる可能性が高い。   Patent Document 2 discloses a technique relating to an acidic liquid food having antibacterial properties, prepared using fermented milk products, and having antibacterial properties of pH 4.6 or lower. However, only by preparing an acidic liquid food having a pH of 4.6 using fermented milk products as a raw material as in the present invention, tube obstruction due to backflow of gastric acid and bacteriostatic properties due to acidic substances can be obtained. It is difficult to maintain good emulsification stability including viscosity and long-term storage. In particular, when a high calorie liquid food is used, the viscosity is high, and there is a high possibility that the emulsion stability cannot be maintained when stored for a long time.

特許文献3には、栄養剤を酸性とすることで、チューブ詰まりや細菌汚染等が生じにくく、味や風味にバリエーションがあり摂取しやすいことを目的として、蛋白質を含有する酸性液状経腸栄養剤に関する技術が開示されている。これは、蛋白質が酸性ホエイ蛋白質分離物及びコラーゲンペプチドからなり、乳化剤が有機酸モノグリセリド及び重合度4〜10のポリグリセリンとオレイン酸とのモノエステルであるポリグリセリン脂肪酸エステルからなっている。しかし、この場合においても、酸性下で凝集しにくいホエー蛋白質分離物と、ホエー蛋白質の加熱凝集の発生を抑制させる目的の有機酸モノグリセリドと、水への分散性が悪い有機酸モノグリセリドを水中に均質に分散させる目的のポリグリセリン脂肪酸エステルを用いpHを3.0〜4.2に調整することにより、胃酸の逆流によるチューブ閉塞や酸性物質による静菌性を得ることができても、長期保存を含めた乳化安定性を良好に保つことが困難である。特に高熱量流動食とした場合は、粘度が高くなるばかりか、蛋白質の凝集を抑制しきれなくなって凝集物が発生し、もはや良好なチューブ流動性を得ることが困難となる。   Patent Document 3 discloses that an acidic liquid enteral nutrient containing protein for the purpose of making the nutrients acidic so that tube clogging and bacterial contamination are less likely to occur, and there are variations in taste and flavor, making it easy to ingest. Techniques related to this are disclosed. The protein is composed of an acidic whey protein isolate and a collagen peptide, and the emulsifier is composed of an organic acid monoglyceride and a polyglycerin fatty acid ester which is a monoester of polyglycerin and oleic acid having a polymerization degree of 4-10. However, even in this case, the whey protein isolate that does not easily aggregate under acidic conditions, the organic acid monoglyceride for the purpose of suppressing the occurrence of heat aggregation of the whey protein, and the organic acid monoglyceride that is poorly dispersible in water are homogeneously mixed in water. By adjusting the pH to 3.0-4.2 using the polyglycerin fatty acid ester intended to be dispersed in the tube, long-term storage can be achieved even if tube clogging due to backflow of gastric acid or bacteriostatic properties due to acidic substances can be obtained. It is difficult to maintain good emulsification stability. In particular, in the case of a high calorie liquid food, not only does the viscosity increase, but protein aggregation cannot be suppressed and aggregates are generated, making it difficult to obtain good tube fluidity.

特許文献4には、酸性流動食用耐酸耐熱性向上剤に関する技術が開示されている。これは、環状体含有量が25%以下であるポリグリセリンとステアリン酸とがエステル化されたポリグリセリン脂肪酸エステルを含有させることで課題を達成する技術である。また実施例には、蛋白質として酸性ホエー蛋白が、乳化剤としてモノステアリン酸デカグリセリン及びジステアリン酸デカグリセリンを使用した例が示されている。しかし、酸性下で凝集しにくい酸性ホエー蛋白と、蛋白質の凝集抑制効果に優れるポリグリセリン脂肪酸エステルを用いるのみでは、胃酸の逆流によるチューブ閉塞や酸性物質による静菌性を得ることができても、長期保存を含めた乳化安定性を良好に保つことができないおそれがある。特に高熱量流動食とした場合は、粘度が高くなるばかりか、蛋白質の凝集を抑制しきれなくなって凝集物が発生し、もはや良好なチューブ流動性を得ることが困難となる。   Patent Document 4 discloses a technique related to an acid heat resistance improver for acidic liquid food. This is a technique for achieving the object by including a polyglycerin fatty acid ester in which polyglycerin having a cyclic content of 25% or less and stearic acid are esterified. In the examples, acidic whey protein is used as the protein, and decaglycerol monostearate and decaglycerol distearate are used as emulsifiers. However, by using only acidic whey protein that does not easily aggregate under acidic conditions and polyglycerin fatty acid ester that is excellent in protein aggregation suppression effect, tube clogging due to reflux of gastric acid and bacteriostatic properties due to acidic substances can be obtained. There is a possibility that the emulsion stability including long-term storage cannot be kept good. In particular, in the case of a high calorie liquid food, not only does the viscosity increase, but protein aggregation cannot be suppressed and aggregates are generated, making it difficult to obtain good tube fluidity.

上記のとおり、高熱量でありながら、良好なチューブ流動性と静菌性の機能を備えた液状組成物とするために、低粘度かつ耐酸性を有する液状栄養組成物、加えて浸透圧性の下痢を抑制するため浸透圧が低く、長期保存を可能とするため、熱殺菌を経た後においても長期にわたる乳化安定性が高い液状栄養組成物は、これまでになかった。   As described above, a liquid nutritional composition having low viscosity and acid resistance, in addition to osmotic diarrhea, in order to obtain a liquid composition having a good tube fluidity and bacteriostatic function while having a high calorific value. In order to suppress this, the osmotic pressure is low, and long-term storage is possible. Therefore, there has never been a liquid nutritional composition having high emulsification stability over a long period even after heat sterilization.

特開2010−4792号公報JP 2010-4792 A 国際公開第2005/094850号公報International Publication No. 2005/094850 特開2007−126379号公報JP 2007-126379 A 特開2011−10632号公報JP 2011-10632 A

本発明は、高熱量でありながら、良好なチューブ流動性と静菌性の機能を備えた液状組成物を提供することを課題とする。さらには、乳化安定性が高く、好ましくは浸透圧が低い、長期保存が可能な液状栄養組成物を提供することである。   This invention makes it a subject to provide the liquid composition provided with favorable tube fluidity | liquidity and a bacteriostatic function, although it is high calorie | heat amount. Furthermore, it is to provide a liquid nutritional composition having high emulsification stability, preferably low osmotic pressure and capable of long-term storage.

本発明者らは、鋭意検討したところ、特定のペプチド、澱粉分解物、乳化剤、および油脂を使用すると、液状栄養組成物ができることを見出し、本発明を完成させた。本発明は、以下の第1<1>から第10<10>の発明からなる。   As a result of intensive studies, the present inventors have found that a liquid nutritional composition can be formed by using a specific peptide, starch degradation product, emulsifier, and oil and fat, and have completed the present invention. The present invention includes the following first <1> to tenth <10> inventions.

<1>蛋白質、糖質、乳化剤、油脂、及び水を含む液状栄養組成物であって、
蛋白質(A)の配合量が2〜11質量%、糖質(B)の配合量が10〜35質量%、乳化剤(C)及び油脂(D)の配合量の合計が1〜13質量%であり、
蛋白質(A)として、コラーゲンペプチド、及び重量平均分子量が1000〜5000の植物性ペプチドを少なくとも含有し、
糖質(B)として、数平均分子量が400〜900である澱粉分解物を少なくとも含有し、
乳化剤(C)として、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル並びに(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドを少なくとも含有し、
油脂(D)として、融点が−30℃〜45℃である油脂を少なくとも含有し、
pHが2.0〜5.0である液状栄養組成物。
<1> A liquid nutritional composition containing protein, carbohydrate, emulsifier, fat and water, and water,
The amount of protein (A) is 2 to 11% by mass, the amount of carbohydrate (B) is 10 to 35% by mass, and the total amount of emulsifier (C) and fat (D) is 1 to 13% by mass. Yes,
The protein (A) contains at least a collagen peptide and a vegetable peptide having a weight average molecular weight of 1000 to 5000,
As a carbohydrate (B), it contains at least a starch degradation product having a number average molecular weight of 400 to 900,
As the emulsifier (C), (i) a polyglycerol fatty acid ester having an average degree of polymerization of polyglycerol of 6 to 20 and a main fatty acid of oleic acid and / or myristic acid, and (ii) a main fatty acid having 12 to 22 carbon atoms. Containing at least monoglyceride which is a saturated fatty acid of
As fats and oils (D), it contains at least fats and oils having a melting point of -30 ° C to 45 ° C,
A liquid nutritional composition having a pH of 2.0 to 5.0.

<2>前記乳化剤(C)において、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステルと、(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドとの含有比率が、1:0.1〜1:2.5である、前記の<1>に記載の液状栄養組成物。 <2> In the emulsifier (C), (i) a polyglycerol fatty acid ester having an average polymerization degree of polyglycerol of 6 to 20 and a main fatty acid of oleic acid and / or myristic acid; and (ii) a main fatty acid. Liquid nutrition composition as described in said <1> whose content ratio with monoglyceride which is a C12-C22 saturated fatty acid is 1: 0.1-1: 2.5.

<3>コラーゲンペプチド及び重量平均分子量が1000〜5000の植物性ペプチドを蛋白質(A)全体の50質量%以上、数平均分子量が400〜900の澱粉分解物を糖質(B)全体の50質量%以上、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル並びに(ii)主たる脂肪酸の炭素数が12〜22である飽和脂肪酸であるモノグリセリドを乳化剤(C)全体の70質量%以上、融点が−30℃〜45℃である油脂を油脂(D)全体の70質量%以上含む、前記の<1>〜<2>のいずれかに記載の液状栄養組成物。 <3> Collagen peptide and plant peptide having a weight average molecular weight of 1000 to 5000 are 50% by mass or more of the whole protein (A), and starch degradation product having a number average molecular weight of 400 to 900 is 50 mass of the whole carbohydrate (B). % Or more, (i) the average degree of polymerization of polyglycerol is 6 to 20, and the main fatty acid is oleic acid and / or myristic acid, and (ii) the main fatty acid has 12 to 22 carbon atoms. <1> to <2> above, wherein the monoglyceride which is a saturated fatty acid contains 70% by mass or more of the whole emulsifier (C) and the oil having a melting point of −30 ° C. to 45 ° C. is 70% by mass or more of the whole fat and oil (D). Liquid nutrition composition in any one of.

<4>油脂(D)と乳化剤(C)との質量比率が1:6〜3:1である、前記の<1>〜<3>のいずれかに記載の液状栄養組成物。 <4> Liquid nutrition composition in any one of said <1>-<3> whose mass ratio of fats and oils (D) and an emulsifier (C) is 1: 6-3: 1.

<5>融点が−30℃〜45℃である油脂として中鎖脂肪酸トリグリセリドを含有することを特徴とする、前記の<1>〜<4>のいずれかに記載の液状栄養組成物。 <5> The liquid nutritional composition according to any one of <1> to <4> above, which contains a medium-chain fatty acid triglyceride as an oil having a melting point of −30 ° C. to 45 ° C.

<6>蛋白質(A)が、コラーゲンペプチド、重量平均分子量1000〜5000の植物性ペプチド、及びアミノ酸からなる、前期の<1>〜<5>のいずれかに記載の液状栄養組成物。 <6> The liquid nutritional composition according to any one of <1> to <5> in the previous period, wherein the protein (A) comprises a collagen peptide, a vegetable peptide having a weight average molecular weight of 1000 to 5000, and an amino acid.

<7>コラーゲンペプチドの重量平均分子量が2000〜50000である、前記の<1>〜<6>のいずれかに記載の液状栄養組成物。 <7> The liquid nutritional composition according to any one of <1> to <6>, wherein the collagen peptide has a weight average molecular weight of 2000 to 50000.

<8>さらに食物繊維(E)を0.1質量%〜5質量%含有し、
当該食物繊維(E)が、難消化性デキストリン、イヌリン、及びポリデキストロースからなる群より選ばれる、1種又は2種以上である、前記の<1>〜<7>のいずれかに記載の液状栄養組成物。
<8> Further contains 0.1% to 5% by weight of dietary fiber (E),
The liquid according to any one of <1> to <7>, wherein the dietary fiber (E) is one or more selected from the group consisting of indigestible dextrin, inulin, and polydextrose. Nutritional composition.

<9>植物性ペプチドが大豆ペプチドである、前記の<1>〜<8>のいずれかに記載の液状栄養組成物。 <9> The liquid nutrition composition according to any one of <1> to <8>, wherein the vegetable peptide is a soybean peptide.

本発明によれば、高熱量でありながら、良好なチューブ流動性と静菌性とを備えた液状組成物とするために、低粘度かつ耐酸性を有する液状栄養組成物を提供できる。さらには、酸性下で乳化安定性が良好な液状栄養組成物を提供でき、熱殺菌を経た後においても長期保存が可能である。加えて、浸透圧を低くすることで、浸透圧性の下痢を抑制することができる。   ADVANTAGE OF THE INVENTION According to this invention, in order to set it as the liquid composition provided with favorable tube fluidity | liquidity and bacteriostatic property, although it is high calorie | heat amount, the liquid nutrition composition which has low viscosity and acid resistance can be provided. Furthermore, it is possible to provide a liquid nutritional composition having good emulsification stability under acidic conditions, and can be stored for a long time even after being subjected to heat sterilization. In addition, osmotic diarrhea can be suppressed by lowering the osmotic pressure.

本発明の液状栄養組成物は、酸性下にもかかわらず、乳化安定性が良好である。一般的な中性の液状栄養組成物は、加水分解されていないカゼイネートや乳蛋白質濃縮物(総合乳蛋白質、MPC、TMPなどとも言われる)や酸性乳ホエー(乳ホエー分離物、分画乳ホエー、WPIなどとも言われる)や大豆蛋白質が配合され、これらがもつ乳化機能により乳化安定性を維持している。しかし、これらの蛋白質は酸性域に等電点を持つため、酸性になると凝集して、乳化機能を失い、酸凝集を比較的起こしにくい加工方法で製造された酸性乳ホエーも、本発明のような高熱量やミネラルを含む環境下で熱殺菌すると凝集が発生し、乳化機能を失う。このため一般的な液状栄養組成物で用いられる蛋白質の乳化機能は、酸性下では効果を発揮できない。本発明では、蛋白質(A);コラーゲンペプチド及び重量平均分子量が1000〜5000の植物性ペプチド、糖質(B);数平均分子量が400〜900である澱粉分解物、乳化剤(C);(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル、及び(ii)主たる脂肪酸の炭素数が12〜22の飽和脂肪酸であるモノグリセリド、及び油脂(D);融点が−30℃〜45℃である油脂で、構成する液状栄養組成物が、酸性下でも乳化安定性が良好となることが明らかとなった。このなかで最も主要な機能となる界面活性能は、乳化剤(C)(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸又はミリスチン酸であるポリグリセリン脂肪酸エステルが負う。   The liquid nutritional composition of the present invention has good emulsion stability despite being acidic. Common neutral liquid nutritional compositions include non-hydrolyzed caseinates and milk protein concentrates (also known as total milk protein, MPC, TMP, etc.) and acidic milk whey (milk whey isolate, fractionated whey) , WPI, etc.) and soy protein are blended, and their emulsification function maintains their emulsion stability. However, since these proteins have an isoelectric point in the acidic region, acidic milk whey produced by a processing method that aggregates when it becomes acidic, loses its emulsifying function, and is relatively less likely to cause acid aggregation is also present in the present invention. When heat sterilized in an environment containing a high amount of heat or minerals, aggregation occurs and the emulsification function is lost. For this reason, the emulsifying function of proteins used in general liquid nutritional compositions cannot exhibit an effect under acidic conditions. In the present invention, protein (A); collagen peptide and vegetable peptide having a weight average molecular weight of 1000 to 5000, carbohydrate (B); starch degradation product having a number average molecular weight of 400 to 900, emulsifier (C); A polyglycerin fatty acid ester in which the average degree of polymerization of polyglycerol is 6 to 20 and the main fatty acid is oleic acid and / or myristic acid, and (ii) a monoglyceride in which the main fatty acid is a saturated fatty acid having 12 to 22 carbon atoms And fat (D); it was revealed that the liquid nutritional composition comprising the fat and oil having a melting point of −30 ° C. to 45 ° C. has good emulsification stability even under acidic conditions. Among these, the surface active ability which is the most main function is borne by the polyglycerol fatty acid ester in which the average polymerization degree of the emulsifier (C) (i) polyglycerol is 6 to 20 and the main fatty acid is oleic acid or myristic acid. .

(乳化剤(C)(i)ポリグリセリン脂肪酸エステルと蛋白質(A))
本発明で蛋白質(A)として必須のコラーゲンペプチドおよび重量平均分子量1000〜5000の植物性ペプチドは、前記(i)ポリグリセリン脂肪酸エステルとの疎水性相互作用による複合体を形成せず、前記(i)ポリグリセリン脂肪酸エステルが乳化界面に吸着することを妨げない特徴を持つ。コラーゲンペプチドのアミノ酸組成は、疎水性アミノ酸が非常に少ないため複合体を形成しない特徴を持つ。重量平均分子量1000〜5000の植物性ペプチドは、加水分解前に有していた疎水性領域が充分に分解されているため複合体を形成しない性質を持つ。また、重量平均分子量1000〜5000の植物性ペプチドは、加水分解前に有していた乳化機能が残存していないため、乳化界面で前記(i)ポリグリセリン脂肪酸エステルと競合しない特徴も持ち合わせる。さらには、後述する局所的濃度勾配による乳化粒子の凝集を引き起こさないメリットを持つ。
(Emulsifier (C) (i) Polyglycerin fatty acid ester and protein (A))
The collagen peptide essential as the protein (A) in the present invention and the vegetable peptide having a weight average molecular weight of 1000 to 5000 do not form a complex due to hydrophobic interaction with the (i) polyglycerin fatty acid ester, and the (i ) It does not prevent polyglycerin fatty acid esters from adsorbing to the emulsifying interface. The amino acid composition of the collagen peptide has a characteristic that it does not form a complex because there are very few hydrophobic amino acids. The vegetable peptide having a weight average molecular weight of 1000 to 5000 has a property of not forming a complex because the hydrophobic region possessed before hydrolysis is sufficiently degraded. Moreover, since the emulsification function which the weight average molecular weight 1000-5000 had before hydrolysis does not remain, it has the characteristic which does not compete with the said (i) polyglycerol fatty acid ester in an emulsification interface. Furthermore, it has the merit of not causing aggregation of emulsified particles due to a local concentration gradient described later.

(乳化剤(C)(i)ポリグリセリン脂肪酸エステルと糖質(B))
本発明で必須の数平均分子量400〜900の澱粉分解物もまた、前記(i)ポリグリセリン脂肪酸エステルとの疎水性相互作用による複合体を形成せず、乳化機能を妨げない特徴を持つ。加水分解されていない澱粉はその分子が螺旋構造をとり、その螺旋で形成される内側は疎水性となるため、前記(i)ポリグリセリン脂肪酸エステルの脂肪酸部分が螺旋の内側に取り込まれる。しかし、平均分子量が小さい澱粉分解物は、前記(i)ポリグリセリン脂肪酸エステルが取り込まれるほどの螺旋構造ができにくい性質を持つ。またペプチドとともに分子の占有体積が小さい成分は、局所的濃度勾配による乳化粒子の凝集を起こさないメリットも持つ。局所的濃度勾配とは、複数の乳化粒子間の距離が偶発的に近くなるとその間のスペースが狭くなり、占有体積が大きな分子は、その間の水相領域から必然的に排除されてできる濃度勾配を指す。その濃度勾配による浸透圧を解消するために、水分子も乳化粒子間から排除され濃度勾配が回復するが、水分子が排除されると2つの乳化粒子が接近し接触することになる。この現象が進めば乳化粒子の凝集、つまり乳化不安定化に繋がる。
(Emulsifier (C) (i) Polyglycerin fatty acid ester and carbohydrate (B))
The starch hydrolyzate having a number average molecular weight of 400 to 900, which is essential in the present invention, also has a characteristic that it does not form a complex due to hydrophobic interaction with the (i) polyglycerol fatty acid ester and does not hinder the emulsifying function. Non-hydrolyzed starch has a helical structure in its molecule, and the inside formed by the helix is hydrophobic, so that the fatty acid portion of (i) polyglycerin fatty acid ester is incorporated inside the helix. However, a starch degradation product having a small average molecular weight has a property that it is difficult to form a helical structure enough to incorporate the (i) polyglycerol fatty acid ester. In addition, a component having a small molecule-occupied volume together with a peptide has a merit of preventing aggregation of emulsified particles due to a local concentration gradient. The local concentration gradient means that when the distance between a plurality of emulsified particles is accidentally close, the space between them becomes narrow, and molecules with a large occupied volume have a concentration gradient that is inevitably excluded from the aqueous phase region between them. Point to. In order to eliminate the osmotic pressure due to the concentration gradient, water molecules are also excluded from between the emulsified particles, and the concentration gradient is restored. However, when the water molecules are excluded, the two emulsified particles approach and come into contact with each other. If this phenomenon progresses, it will lead to aggregation of the emulsified particles, that is, destabilization of the emulsion.

(乳化剤(C)(i)ポリグリセリン脂肪酸エステルと乳化剤(C)(ii)モノグリセリド)
前記(i)ポリグリセリン脂肪酸エステルは乳化剤の中でも親水性に大きく偏った性質を持ち、乳化界面でも比較的水相部に近い位置に偏在する。よって、疎水性に偏った性質を持つ乳化剤(モノグリセリド)を併用することが望まれる。前記(i)ポリグリセリン脂肪酸エステルと前記(ii)モノグリセリドとの組み合わせによれば、乳化界面に均一に乳化剤を存在させることができる。また、本発明は栄養組成上の要求より多量の澱粉分解物を配合するため、わずかでも残存する澱粉分解物の螺旋構造による疎水性部分が無視できなくなる。前記(ii)モノグリセリドは、前記(i)ポリグリセリン脂肪酸エステルよりも優先して澱粉分解物と複合体を形成するので、上記ポリグリセリン脂肪酸エステルが充分に乳化界面に吸着できるようになる。
(Emulsifier (C) (i) Polyglycerin fatty acid ester and emulsifier (C) (ii) monoglyceride)
The (i) polyglycerin fatty acid ester has properties that are largely biased toward hydrophilicity among emulsifiers, and is unevenly distributed at a position relatively close to the aqueous phase portion even at the emulsifying interface. Therefore, it is desirable to use an emulsifier (monoglyceride) having a property biased toward hydrophobicity. According to the combination of the (i) polyglycerin fatty acid ester and the (ii) monoglyceride, an emulsifier can be uniformly present at the emulsification interface. In addition, since the present invention contains a larger amount of starch degradation product than required in nutritional composition, the hydrophobic portion due to the helical structure of the remaining starch degradation product cannot be ignored. Since the (ii) monoglyceride forms a complex with the starch degradation product in preference to the (i) polyglycerin fatty acid ester, the polyglycerin fatty acid ester can be sufficiently adsorbed on the emulsifying interface.

(乳化剤(C)(i)ポリグリセリン脂肪酸エステルと油脂(D))
本発明で必須の、融点が−30℃〜45℃である油脂とは、融点が低い油脂を意味している。融点が低いことは油脂としての粘性が低いことといえるが、粘性が低いと乳化粒子を微細に分断しやすいメリットがある。融点が低い油脂の中でも、特に親水性の油脂が好ましい。親水性に大きく偏った前記(i)ポリグリセリン脂肪酸エステルとの相性が良く、良好な乳化構造が得られる。親水性の油脂としては、例えば、中鎖脂肪酸トリグリセライドが好ましいものとして挙げられる。
(Emulsifier (C) (i) Polyglycerin fatty acid ester and fat (D))
The fat and oil having a melting point of −30 ° C. to 45 ° C. essential in the present invention means a fat and oil having a low melting point. A low melting point can be said to have a low viscosity as an oil or fat, but if the viscosity is low, there is an advantage that the emulsified particles are easily finely divided. Among oils and fats having a low melting point, hydrophilic oils and fats are particularly preferable. Good compatibility with the (i) polyglycerin fatty acid ester which is largely biased in hydrophilicity, and a good emulsified structure can be obtained. As hydrophilic fats and oils, for example, medium chain fatty acid triglycerides are preferable.

(栄養組成物)
本発明の液状栄養組成物は、流動食、濃厚流動食、総合栄養食などとよばれる、液状で流動性のある栄養組成物が代表的なものであるが、これに限られるものではない。基本組成としては、水、蛋白質、脂質、及び糖質から構成され、通常は更に、食物繊維、ビタミン、及びミネラルが含まれる。そのバランスは厚生労働省において策定された「日本人の食事摂取基準(2010年度版)」などを参考にして、それぞれの目的に則して設定される。ただし、「日本人の食事摂取基準(2010年度版)」は健常人を対象に設定されているため、1日あたりのエネルギー必要量は1350kcal〜2750kcalであるが、流動食を使用する人は、寝たきりであり、基礎代謝量が低下している場合が多く、1日の必要熱量は800kcal〜1500kcalで設定されることが多い。
(Nutrition composition)
The liquid nutritional composition of the present invention is typically a liquid and fluid nutritional composition called liquid food, concentrated liquid food, or integrated nutritional food, but is not limited thereto. The basic composition is composed of water, protein, lipid, and sugar, and usually further includes dietary fiber, vitamins, and minerals. The balance is set according to each purpose with reference to “Japanese food intake standards (2010 edition)” formulated by the Ministry of Health, Labor and Welfare. However, since the “Japanese dietary intake standard (2010 version)” is set for healthy individuals, the energy requirement per day is 1350 kcal to 2750 kcal, but those who use liquid foods In many cases, the person is bedridden and has a low basal metabolic rate, and the daily calorific value is often set at 800 kcal to 1500 kcal.

(蛋白質(A)の概要)
蛋白質(A)は栄養学的にいう蛋白質であり、ペプチド及び遊離アミノ酸を含む。蛋白質(A)の配合量は液状栄養組成物全体の2〜11質量%である。2質量%より少ないと栄養学的な価値が低くなり、11質量%より多いと栄養学的に腎臓に負担をかけ腎機能が衰えた使用者への悪影響が大きくなるばかりか、粘度が大きくなりすぎチューブを流下しにくくなる。コラーゲンペプチド及び重量平均分子量1000〜5000の植物性ペプチドの含有量は蛋白質(A)全体の50質量%以上とすることが好ましく、80質量%以上とすることが特に好ましい。なお、蛋白質(A)は、実質的にペプチドおよび必須アミノ酸としての遊離アミノ酸のみから構成されることが望ましい。アミノ酸としては例えば、L−イソロイシン、L−ロイシン、L−リジン、L−メチオニン、L−フェニルアラニン、L−スレオニン、L−トリプトファン、L−バリン、L−ヒスチジンなどが挙げられる。
(Outline of protein (A))
Protein (A) is a nutritional protein and includes a peptide and a free amino acid. The compounding quantity of protein (A) is 2-11 mass% of the whole liquid nutrition composition. If it is less than 2% by mass, the nutritional value will be low, and if it is more than 11% by mass, the nutrition will be burdened on the kidneys and the adverse effects on users with impaired kidney function will increase, and the viscosity will increase. It becomes difficult to flow down the tube too much. The content of the collagen peptide and the vegetable peptide having a weight average molecular weight of 1000 to 5000 is preferably 50% by mass or more, particularly preferably 80% by mass or more of the whole protein (A). The protein (A) is preferably substantially composed only of a peptide and a free amino acid as an essential amino acid. Examples of amino acids include L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-valine, L-histidine and the like.

(蛋白質(A)のコラーゲンペプチド)
本発明は、コラーゲンペプチドを用いることが必須である。コラーゲンペプチドはゼラチンの酸、アルカリ又は酵素による分解物であり、その重量平均分子量は2000〜50000が好ましく、最も好ましくは4000〜20000である。2000よりも小さいと遊離アミノ酸や低分子のペプチドにより浸透圧が高くなるおそれがあり、50000よりも大きいとゲル化性が充分に失われず、液状栄養組成物のゲル化又は高粘度化を生じるおそれがある。コラーゲンペプチドは容易に溶解し、酸性領域で熱殺菌を経る場合においても不溶化しにくいという利点を持つ。コラーゲンペプチドの由来としては、牛や豚や魚や鳥などの骨や皮や鱗や鶏冠などが挙げられる。
(Collagen peptide of protein (A))
In the present invention, it is essential to use a collagen peptide. Collagen peptide is a degradation product of gelatin by acid, alkali or enzyme, and its weight average molecular weight is preferably 2000 to 50000, most preferably 4000 to 20000. If it is smaller than 2000, the osmotic pressure may increase due to free amino acids or low molecular weight peptides, and if it is larger than 50000, the gelling property may not be sufficiently lost, and the liquid nutritional composition may be gelled or increased in viscosity. There is. Collagen peptides have the advantage that they dissolve easily and are not easily insolubilized even when heat-sterilized in an acidic region. Examples of the origin of the collagen peptide include bones, skins, scales and chicken crowns of cows, pigs, fish and birds.

(蛋白質(A)の植物性ペプチド)
本発明は、重量平均分子量が1000〜5000の植物性ペプチドを用いることが必須である。好ましくは植物性ペプチドの重量平均分子量は2000〜3000である。重量平均分子量が1000より小さいと浸透圧が上昇し不適である。逆に5000より大きいと、加水分解前の蛋白質の性質(酸性で不溶又は加熱凝集しやすい性質)が残存し、ペプチド自身が不溶化し白濁沈澱する。また5000より大きいと、微細な粒径が得られず乳化安定性が低下する。
(Plant peptide of protein (A))
In the present invention, it is essential to use a vegetable peptide having a weight average molecular weight of 1000 to 5000. Preferably, the vegetable peptide has a weight average molecular weight of 2000 to 3000. If the weight average molecular weight is less than 1000, the osmotic pressure increases, which is not suitable. On the other hand, if it exceeds 5000, the properties of the protein before hydrolysis (acid, insolubility or property of being easily aggregated by heating) remain, and the peptide itself becomes insoluble and cloudy. On the other hand, if it is larger than 5000, a fine particle size cannot be obtained and the emulsion stability is lowered.

(分解度の測定方法)
本発明の植物性ペプチドの分解度の測定方法は、一般的に用いられるOPA(o-Phthalaldehyde)法などを用いることができる。
(Measurement method of resolution)
As a method for measuring the degradation degree of the vegetable peptide of the present invention, a generally used OPA (o-Phthalaldehyde) method or the like can be used.

(アミノ酸)
前述のようにコラーゲンペプチドなどのアミノ酸スコアの低いペプチドを使用する場合は、最終製品として一定のアミノ酸スコアを保つために遊離のアミノ酸を配合することが好ましい。例えば、ホエイペプチドとコラーゲンペプチドを1:1で混合した場合は、L−トリプトファン、L−ロイシン、L−メチオニン又はL−システイン、L−ヒスチジン、L−バリン、及び、L−フェニルアラニン又はL−チロシンの配合が好ましい。アミノ酸スコアを90〜100にするためには、この中でもL−フェニルアラニン又はL−チロシンを多量に配合しなければならないが、酸性領域ではL−フェニルアラニンのほうが溶解性や保存安定性の観点から好ましい。
(amino acid)
As described above, when a peptide having a low amino acid score such as a collagen peptide is used, it is preferable to mix a free amino acid in order to maintain a certain amino acid score as a final product. For example, when whey peptide and collagen peptide are mixed at 1: 1, L-tryptophan, L-leucine, L-methionine or L-cysteine, L-histidine, L-valine, and L-phenylalanine or L-tyrosine Is preferable. Among them, L-phenylalanine or L-tyrosine must be added in a large amount in order to make the amino acid score 90 to 100, but L-phenylalanine is more preferable in the acidic region from the viewpoint of solubility and storage stability.

(蛋白質(A)の栄養バランス)
本発明の蛋白質(A)は、エネルギー比率で8〜32%が好ましく、より好ましくは12〜24%、最も好ましくは12〜20%である。臨床栄養的には、PEM(Protein Energy Malnutrition;蛋白質・エネルギー低栄養状態)と呼ばれる栄養状態を起こさないため、またこの栄養状態から回復させるため、単位容積又は単位熱量あたりに含まれる蛋白質成分の多いことが望まれている。PEM状態にあると、様々な疾病や術後の回復が遅れ、最近では褥瘡を発症しやすく治癒し難い問題が指摘されている。しかし、蛋白質成分が多い場合には、蛋白質の老廃物を処理する腎臓に負担がかかり、特に腎臓の機能が低下している高齢者においては、血中尿素窒素が上昇するため好ましくない。また、蛋白質濃度が高いと、粘度や浸透圧が上昇したりする。蛋白質濃度が低い場合は、一定の熱量を確保するため、相対的に糖質又は油脂を増量することが必要となり、糖質を増量した場合は後述するような食後血糖値の問題が、脂質を増量した場合は、高脂血症などの問題が生じる。
(Nutrition balance of protein (A))
The protein (A) of the present invention preferably has an energy ratio of 8 to 32%, more preferably 12 to 24%, and most preferably 12 to 20%. In terms of clinical nutrition, since there is no nutritional state called PEM (Protein Energy Malnutrition), and to recover from this nutritional state, many protein components are contained per unit volume or unit calorie. It is hoped that. In the PEM state, various diseases and postoperative recovery are delayed, and recently it has been pointed out that it is easy to develop pressure ulcers and is difficult to cure. However, when there are many protein components, the kidney which processes a protein waste product will be burdened, and especially in the elderly in which the function of the kidney has fallen, since blood urea nitrogen will rise, it is not preferable. Moreover, when a protein concentration is high, a viscosity and an osmotic pressure will rise. When the protein concentration is low, it is necessary to increase the amount of sugar or fat relatively in order to secure a certain amount of heat. When the amount of sugar is increased, the problem of postprandial blood glucose level as described later may When the dose is increased, problems such as hyperlipidemia occur.

(蛋白質(A)の分析法とアミノ酸スコア)
本発明の蛋白質(A)の含有量は、ケルダール法などによって窒素含量を測定することによって算出される。よって、蛋白質の消化態である遊離アミノ酸であっても、蛋白質分解物(ペプチド)であっても、栄養学的には蛋白質に含まれる。栄養補給を目的とするために、栄養学的に良質であることが望ましい。例えば、アミノ酸スコアという指標がある。本発明の栄養組成物は、使用する蛋白質のアミノ酸スコアは限定しないが、栄養組成物としては、少なくとも70以上、好ましくは80以上、最も好ましくは100である。
(Protein (A) analysis method and amino acid score)
The content of the protein (A) of the present invention is calculated by measuring the nitrogen content by the Kjeldahl method or the like. Therefore, no matter whether it is a free amino acid that is a digestion state of a protein or a protein degradation product (peptide), it is nutritionally included in the protein. For nutritional purposes, it is desirable to have a nutritionally good quality. For example, there is an index called an amino acid score. In the nutritional composition of the present invention, the amino acid score of the protein used is not limited, but the nutritional composition is at least 70 or more, preferably 80 or more, and most preferably 100.

(糖質(B)の概要)
本発明の糖質(B)は、数平均分子量400〜900の澱粉分解物を含有することが必須である。本発明の糖質(B)液状栄養組成物全体の配合量は10〜35質量%であり、10質量%より少ないと栄養学的な価値が低くなり、35質量%より多いと浸透圧や粘度が高くなり過ぎる。糖質(B)の配合量は、好ましくは15〜30質量%、より好ましくは20〜30質量%である。本発明の糖質(B)のうちの数平均分子量400〜900の澱粉分解物の割合は、50質量%以上が好ましく、より好ましくは70質量%以上、最も好ましくは90質量%以上である。糖質(B)の全量を数平均分子量400〜900の澱粉分解物とすることもできる。糖質中の数平均分子量400〜900の澱粉分解物の割合が少ない場合は、良好なチューブ流動性や好ましい乳化安定性が得られ難い。
(Outline of carbohydrate (B))
It is essential that the saccharide (B) of the present invention contains a starch degradation product having a number average molecular weight of 400 to 900. The total amount of the saccharide (B) liquid nutritional composition of the present invention is 10 to 35% by mass, and if it is less than 10% by mass, the nutritional value is low. Becomes too high. The compounding quantity of saccharide | sugar (B) becomes like this. Preferably it is 15-30 mass%, More preferably, it is 20-30 mass%. The ratio of the starch degradation product having a number average molecular weight of 400 to 900 in the saccharide (B) of the present invention is preferably 50% by mass or more, more preferably 70% by mass or more, and most preferably 90% by mass or more. The total amount of the saccharide (B) may be a starch degradation product having a number average molecular weight of 400 to 900. When the ratio of the starch degradation product having a number average molecular weight of 400 to 900 in the saccharide is small, it is difficult to obtain good tube fluidity and preferable emulsion stability.

(糖質(B)の澱粉分解物)
本発明の糖質(B)として用いられる澱粉分解物の数平均分子量は400〜900であり、好ましくは500〜900である。400より小さいと浸透圧が上昇し、逆に900より大きいと、乳化粒径の粗大化を引き起こし、乳化安定性に悪影響を及ぼす。澱粉分解物とは分子量によってデキストリン、マルトデキストリン、水飴などと呼ばれるものであり、馬鈴薯、コーン、タピオカ、小麦などから得られる澱粉を、酸や酵素などで分解したものである。
(Saccharide (B) starch degradation product)
The number average molecular weight of the starch degradation product used as the saccharide (B) of the present invention is 400 to 900, preferably 500 to 900. If it is less than 400, the osmotic pressure rises. On the other hand, if it is more than 900, the emulsification particle size becomes coarse and the emulsion stability is adversely affected. The starch degradation product is called dextrin, maltodextrin, starch syrup or the like depending on the molecular weight, and is obtained by decomposing starch obtained from potato, corn, tapioca, wheat, etc. with acid or enzyme.

(糖質(B)の栄養バランス)
本発明の糖質(B)は、エネルギー比率で33〜84%が好ましく、より好ましくは51〜78%、最も好ましくは60〜76%である。臨床栄養的には、糖質は比較的速やかにエネルギーに変換される源であるので、エネルギー源としては好ましいが、多量に配合すると食後血糖値の上昇を誘発し、糖尿病などの疾病に悪い影響を与える。また糖質濃度が高いと、粘度や浸透圧が高くなるばかりか、澱粉分解物の濃度が高い場合は前述した局所的濃度勾配による乳化不安定化や、澱粉分解物による乳化剤の取り込みにより乳化安定性に与える悪い影響が大きくなる。糖質濃度が低い場合は、一定の熱量を確保するため、相対的に蛋白質又は油脂を増量することが必要となり、蛋白質を増量した場合は前述したような血中尿素窒素の問題や、脂質を増量した場合は後述するように高脂血症などの問題が生じる。
(Nutritional balance of carbohydrate (B))
The carbohydrate (B) of the present invention preferably has an energy ratio of 33 to 84%, more preferably 51 to 78%, and most preferably 60 to 76%. In terms of clinical nutrition, carbohydrates are preferable as an energy source because they are converted to energy relatively quickly, but when added in large amounts, they increase postprandial blood glucose levels and adversely affect diseases such as diabetes. give. In addition, when the sugar concentration is high, not only the viscosity and osmotic pressure increase, but also when the starch degradation product concentration is high, the emulsion is unstable due to the above-mentioned local concentration gradient or the emulsification by the incorporation of the emulsifier by the starch degradation product. The negative effect on sex is increased. When the sugar concentration is low, it is necessary to increase the amount of protein or fat relatively in order to ensure a certain amount of heat. When the amount of protein is increased, the problem of blood urea nitrogen as described above, or lipid When the dose is increased, problems such as hyperlipidemia occur as described later.

(乳化剤(C)の概要)
本発明の乳化剤(C)は、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル、並びに(ii)主たる視農産が炭素数12〜22の飽和脂肪酸であるモノグリセリドを含有することが必須である。これら乳化剤(i)及び(ii)の合計量は、乳化剤(C)全体の70質量%以上とすることが好ましく、90質量%以上とすることが特に好ましい。乳化剤(C)の全量を前記(i)及び前記(ii)とすることもできる。前記(i)及び(ii)の合計量が、乳化剤(C)全体の70質量%より少ないと、微細な乳化粒子及び乳化安定性が得られない。
(Outline of emulsifier (C))
The emulsifier (C) of the present invention comprises (i) a polyglycerin fatty acid ester in which the average degree of polymerization of polyglycerol is 6 to 20 and the main fatty acid is oleic acid and / or myristic acid, and (ii) the main visual agricultural product. It is essential to contain monoglycerides which are saturated fatty acids having 12 to 22 carbon atoms. The total amount of these emulsifiers (i) and (ii) is preferably 70% by mass or more, particularly preferably 90% by mass or more, based on the entire emulsifier (C). The total amount of the emulsifier (C) may be the above (i) and (ii). If the total amount of (i) and (ii) is less than 70% by mass of the total emulsifier (C), fine emulsified particles and emulsion stability cannot be obtained.

(乳化剤(C)(i)のポリグリセリン脂肪酸エステル)
本発明は、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステルを用いることが必須である。ポリグリセリンの平均重合度はより好ましくは10〜20である。ポリグリセリンの平均重合度が6より小さいと微細な乳化粒子及び乳化安定性が得られない。またエステルの原料とする脂肪酸は、パルミチン酸やステアリン酸などの長鎖飽和脂肪酸では微細な乳化粒子と乳化安定性が得られず、ラウリン酸などの中鎖脂肪酸では泡立ちが強くなるため製造や使用する場面で不都合となる。そのため、ミリスチン酸及び/又はオレイン酸を主たる脂肪酸とすることが必須である。また泡立ちについてはミリスチン酸よりもオレイン酸のほうが良好である。ポリグリセリン脂肪酸エステルにおける脂肪酸の割合では、オレイン酸及び/又はミリスチン酸の合計量が50質量%以上、より好ましくは70%重量以上、最も好ましくは80質量%以上である。ポリグリセリン脂肪酸エステルにおけるオレイン酸及び/又はミリスチン酸の合計量の割合が50質量%より少ないと、微細な乳化粒子と乳化安定性が得られない。
(Polyglycerin fatty acid ester of emulsifier (C) (i))
In the present invention, it is essential to use (i) a polyglycerol fatty acid ester in which the average degree of polymerization of polyglycerol is 6 to 20 and the main fatty acid is oleic acid and / or myristic acid. The average degree of polymerization of polyglycerol is more preferably 10-20. When the average degree of polymerization of polyglycerol is less than 6, fine emulsified particles and emulsion stability cannot be obtained. Fatty acids used as ester raw materials are manufactured and used because long-chain saturated fatty acids such as palmitic acid and stearic acid do not provide fine emulsified particles and emulsion stability, and medium-chain fatty acids such as lauric acid have strong foaming. It becomes inconvenient in the scene to do. Therefore, it is essential to use myristic acid and / or oleic acid as the main fatty acid. Also, oleic acid is better than myristic acid for foaming. In the ratio of fatty acids in the polyglycerin fatty acid ester, the total amount of oleic acid and / or myristic acid is 50% by mass or more, more preferably 70% by weight or more, and most preferably 80% by mass or more. When the ratio of the total amount of oleic acid and / or myristic acid in the polyglycerin fatty acid ester is less than 50% by mass, fine emulsified particles and emulsion stability cannot be obtained.

(乳化剤(C)(ii)モノグリセリド)
本発明は、主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドを用いることが必須である。重合度2以上のグリセリンで微細な乳化粒子と乳化安定性が得られない。またエステルの原料とする脂肪酸は、主として炭素数12〜22の飽和脂肪酸が使用される。そのような飽和脂肪酸としては、パルミチン酸及びステアリン酸等が好ましいものとして挙げられる。オレイン酸やリノール酸やリノレン酸やパルミトオレイン酸など不飽和脂肪酸では微細な乳化粒子と乳化安定性が得られない。この(ii)モノグリセリドにおける脂肪酸の割合では、炭素数12以上22以下の飽和脂肪酸が50質量%以上、より好ましくは70%重量以上、最も好ましくは80質量%以上である。モノグリセリドにおける炭素数12以上22以下の飽和脂肪酸が50質量%より少ないと微細な乳化粒子及び乳化安定性が得られない。
(Emulsifier (C) (ii) Monoglyceride)
In the present invention, it is essential to use a monoglyceride whose main fatty acid is a saturated fatty acid having 12 to 22 carbon atoms. Fine emulsion particles and emulsion stability cannot be obtained with glycerin having a polymerization degree of 2 or more. The fatty acid used as a raw material for the ester is mainly a saturated fatty acid having 12 to 22 carbon atoms. Examples of such saturated fatty acids include palmitic acid and stearic acid. Unsaturated fatty acids such as oleic acid, linoleic acid, linolenic acid and palmitooleic acid cannot provide fine emulsified particles and emulsion stability. In the ratio of fatty acids in this (ii) monoglyceride, saturated fatty acids having 12 to 22 carbon atoms are 50% by mass or more, more preferably 70% by weight or more, and most preferably 80% by mass or more. If the saturated fatty acid having 12 to 22 carbon atoms in the monoglyceride is less than 50% by mass, fine emulsified particles and emulsion stability cannot be obtained.

(油脂(D)の概要)
本発明の油脂(D)は、融点が−30℃〜45℃である油脂を含有することが必須である。融点が−30℃〜45℃である油脂は、油脂(D)全体の70質量%以上とするのが好ましく、90質量%以上とするのが特に好ましい。油脂(D)の全量を融点が−30℃〜45℃である油脂とすることもできる。融点が−30℃〜45℃である油脂が、油脂(D)全体の70質量%より少ないと、微細な乳化粒子と乳化安定性が得られない。
(Outline of oil and fat (D))
It is essential that the oil (D) of the present invention contains an oil having a melting point of -30 ° C to 45 ° C. The fat and oil having a melting point of −30 ° C. to 45 ° C. is preferably 70% by mass or more, and particularly preferably 90% by mass or more, based on the entire fat (D). The total amount of the oil (D) can be an oil having a melting point of -30 ° C to 45 ° C. When the fats and oils having a melting point of −30 ° C. to 45 ° C. are less than 70% by mass of the whole fats and oils (D), fine emulsified particles and emulsion stability cannot be obtained.

(油脂(D)の融点−30℃以上45℃以下である油脂)
本発明で油脂(D)として使用される融点が−30℃〜45℃である油脂は、融点−30℃以下である油脂がより好ましく、融点が10℃以下である油脂が特に好ましく、融点が10℃以下である特に中鎖脂肪やMCTなどとも呼ばれる中鎖脂肪酸トリグリセリドが最も好ましい。融点が45℃より高い油脂では、微細な乳化粒子と乳化安定性が得られない。MCTは、栄養学的にみても消化機能が衰えた患者や高齢者においても効率よく吸収され、またエネルギーに速やかに変換される特徴があり望ましい。融点が−30℃〜45℃である油脂としては、例えば、大豆油、ナタネ油、綿実油、コメ油、コーン油、ゴマ油、落花生油、ヒマワリ油、サフラワー油、椿油、オリーブ油、ヤシ油、一部のパーム油、パーム核油、カカオ脂、豚脂、牛脂、及び魚油などが挙げられる。なお、融点は、常圧における融点を示し、示差走査熱量測定法(DSC)などにより測定することができる。
(Fat and fat (D) having a melting point of -30 ° C to 45 ° C)
In the present invention, the oil having a melting point of −30 ° C. to 45 ° C. used as the oil (D) is more preferably an oil having a melting point of −30 ° C. or less, particularly preferably an oil having a melting point of 10 ° C. or less. Most preferred are medium-chain fatty acid triglycerides, particularly medium-chain fat and MCT, which are 10 ° C. or lower. With fats and oils having a melting point higher than 45 ° C., fine emulsified particles and emulsion stability cannot be obtained. MCT is desirable because it is efficiently absorbed even in patients and elderly people whose digestive functions have declined from a nutritional point of view and can be quickly converted into energy. Examples of fats and oils having a melting point of −30 ° C. to 45 ° C. include soybean oil, rapeseed oil, cottonseed oil, rice oil, corn oil, sesame oil, peanut oil, sunflower oil, safflower oil, camellia oil, olive oil, coconut oil, one Part of palm oil, palm kernel oil, cacao butter, lard, beef tallow, and fish oil. In addition, melting | fusing point shows melting | fusing point in a normal pressure and can be measured by a differential scanning calorimetry (DSC) etc.

(油脂(D)の栄養バランス)
本発明の油脂(D)は、エネルギー比率で8〜35%が好ましく、より好ましくは10〜25%、最も好ましくは12〜20%である。臨床栄養的には、油脂は重量あたりに含まれる熱量(9kcal/g)が蛋白質や糖質(4kcal/g)と比べ高い方が好ましいが、多量に配合すると血清脂質濃度の上昇を誘発し、動脈硬化症などの疾病に悪い影響を与える。油脂濃度が低い場合には、一定の熱量を確保するため、相対的に蛋白質もしくは糖質を増量することが必要となり、蛋白質を増量した場合は前述したような血中尿素窒素の問題や、糖質を増量した場合には前述した食後血糖値の問題が生じる。
(Nutrition balance of fat (D))
The oil and fat (D) of the present invention is preferably 8 to 35% in terms of energy ratio, more preferably 10 to 25%, and most preferably 12 to 20%. In clinical nutrition, oils and fats preferably have a higher calorie content per weight (9 kcal / g) than protein and carbohydrates (4 kcal / g). It adversely affects diseases such as arteriosclerosis. When the fat and oil concentration is low, it is necessary to relatively increase the amount of protein or sugar to ensure a certain amount of heat. When the amount of protein is increased, the problem of blood urea nitrogen as described above, sugar When the quality is increased, the aforementioned postprandial blood glucose level problem occurs.

(油脂(D)の分析法)
本発明の油脂(D)の含有量は、エーテル抽出法、クロロホルム・メタノール混液法、酸分解法、レーゼゴットリーブ法、ゲルベル法などによって測定されるが、極性の高い脂質も充分に回収するため、クロロホルム・メタノール混液法およびレーゼゴットリーブ法が好ましく、これらの測定法であれば、ほぼ同値が得られる。
(Analytical method of fats and oils (D))
The content of the fat (D) of the present invention is measured by an ether extraction method, a chloroform / methanol mixed solution method, an acid decomposition method, a Rosette Gottlieb method, a gel bell method, etc. A chloroform / methanol mixed solution method and a Rosette Gottlieb method are preferable. With these measurement methods, almost the same value can be obtained.

(食物繊維(E))
本発明の食物繊維(E)は、栄養組成物の生理効果を高めるため、本発明の目的を逸脱しない範囲で一般に食用として利用されているものを使用してもよい。食物繊維としては例えば、タマリンドシードガム、グァーガム、グァーガム酵素分解物、小麦胚芽、難消化性デキストリン、大豆食物繊維、プルラン、アラビアガム、難消化性デキストリン、ビートファイバー、低分子化アルギン酸ナトリウム、寒天、キサンタンガム、ジェランガム、サイリウム種皮、セルロース、ポリデキストロース、コーンファイバー、小麦ふすまなどが挙げられる。ただし、本発明の目的である長期の安定性を確保するために水溶性食物繊維が望ましく、その中でも難消化性デキストリン、イヌリン、ポリデキストロースにおいて微細な乳化粒子が得られやすい。
(Dietary fiber (E))
The dietary fiber (E) of the present invention may be one that is generally used as an edible food within the range not departing from the object of the present invention in order to enhance the physiological effect of the nutritional composition. Examples of dietary fiber include tamarind seed gum, guar gum, guar gum enzyme degradation product, wheat germ, indigestible dextrin, soy dietary fiber, pullulan, gum arabic, indigestible dextrin, beet fiber, low molecular weight sodium alginate, agar, Xanthan gum, gellan gum, psyllium seed coat, cellulose, polydextrose, corn fiber, wheat bran and the like. However, water-soluble dietary fiber is desirable in order to ensure long-term stability, which is the object of the present invention. Among them, fine emulsified particles are easily obtained in indigestible dextrin, inulin, and polydextrose.

(ペプチドの配合量と比率)
本発明の蛋白質(A)は、実質的にペプチドおよびアミノ酸のみからなることが好ましい。また、アミノ酸はアミノ酸スコアを高くするための補助的に添加されるものであるため、その大部分はペプチドとして配合されることになる。そのため、ペプチド及びアミノ酸の配合量は蛋白質(A)の配合量と同等で栄養組成物全体の2〜11質量%であり、2質量%より少ないと栄養学的な価値が低くなり、11質量%より多いと腎臓等への負担が増し、前述したように栄養学的な不利益が大きくなるばかりか浸透圧が高くなる。好ましくは3〜8質量%、より好ましくは3〜7質量%である。前述のように、コラーゲンペプチドは容易に溶解し、酸性領域でミネラルを含み、熱殺菌を経る場合においても安定的に溶解する有用性がある一方で、栄養学的には良質でなくアミノ酸スコアが0であることから、コラーゲンペプチドの比率を大きくすることは好ましくない。よって栄養組成物として一定のアミノ酸スコアを保つためには、植物性ペプチドなどのアミノ酸スコアが良好なペプチドや遊離のアミノ酸と併用することが必要である。本発明においては、アミノ酸スコアが良好なペプチドとして、前述のように、重量平均分子量1000〜5000の植物性ペプチドを含む必要がある。コラーゲンペプチドと重量平均分子量1000〜5000の植物性ペプチドの比率は、5:1〜1:5が好ましい。より好ましくは3:1〜1:3であり、最も好ましくは2:1〜1:2である。コラーゲンペプチドの割合が多いと、アミノ酸スコアを補うための遊離アミノ酸により浸透圧が高くなり、重量平均分子量1000〜5000の植物性ペプチドの割合が多いと、微細な乳化粒子と乳化安定性が得られなくなる。なお、ここで、重量平均分子量1000〜5000の植物性ペプチドは、その一部を別のアミノ酸スコアが良好なペプチドに置き換えることができる。アミノ酸スコアが良好なペプチドとは、アミノ酸スコア50以上が望ましい。より好ましくは80以上であり、最も好ましくは100以上である。
(Peptide content and ratio)
The protein (A) of the present invention preferably consists essentially of peptides and amino acids. In addition, since amino acids are supplementarily added to increase the amino acid score, most of them are blended as peptides. Therefore, the amount of the peptide and amino acid is the same as the amount of the protein (A) and is 2 to 11% by mass of the whole nutritional composition. If the amount is less than 2% by mass, the nutritional value is low, and 11% by mass. If it is more, the burden on the kidney and the like will increase, and as described above, the nutritional disadvantage will increase and the osmotic pressure will increase. Preferably it is 3-8 mass%, More preferably, it is 3-7 mass%. As described above, collagen peptides dissolve easily, contain minerals in the acidic region, and have the usefulness of being stably dissolved even when subjected to heat sterilization. Since it is 0, it is not preferable to increase the ratio of the collagen peptide. Therefore, in order to maintain a certain amino acid score as a nutritional composition, it is necessary to use a peptide having a good amino acid score, such as a plant peptide, or a free amino acid. In the present invention, as described above, it is necessary to include a vegetable peptide having a weight average molecular weight of 1000 to 5000 as a peptide having a good amino acid score. The ratio of the collagen peptide to the vegetable peptide having a weight average molecular weight of 1000 to 5000 is preferably 5: 1 to 1: 5. More preferably, it is 3: 1 to 1: 3, and most preferably 2: 1 to 1: 2. When the ratio of collagen peptides is large, the osmotic pressure increases due to free amino acids to supplement the amino acid score, and when the ratio of vegetable peptides having a weight average molecular weight of 1000 to 5000 is large, fine emulsified particles and emulsion stability are obtained. Disappear. Here, a part of the vegetable peptide having a weight average molecular weight of 1000 to 5000 can be replaced with another peptide having a good amino acid score. A peptide having a good amino acid score preferably has an amino acid score of 50 or more. More preferably, it is 80 or more, Most preferably, it is 100 or more.

(乳化剤(C)(i)ポリグリセリン脂肪酸エステルと乳化剤(C)(ii)モノグリセリドとの比率)
本発明の乳化剤(C)のうち、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステルと、(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドとの質量比率は、99:1〜25:75が好ましく、より好ましくは90:10〜35:65、最も好ましくは75:25〜40:60であり、微細な乳化粒子と乳化安定性が得られやすい。
(Emulsifier (C) (i) Ratio of polyglycerin fatty acid ester to emulsifier (C) (ii) monoglyceride)
Among the emulsifiers (C) of the present invention, (i) a polyglycerin fatty acid ester in which the average degree of polymerization of polyglycerol is 6 to 20 and the main fatty acid is oleic acid and / or myristic acid, and (ii) the main fatty acid is The mass ratio with the monoglyceride which is a saturated fatty acid having 12 to 22 carbon atoms is preferably 99: 1 to 25:75, more preferably 90:10 to 35:65, and most preferably 75:25 to 40:60. Fine emulsion particles and emulsion stability are easily obtained.

(油脂と乳化剤の比率)
本発明において小さい乳化粒径を得るためには、油脂(D)と乳化剤(C)の質量比率が重要であり、1:6〜3:1が好ましく、より好ましくは1:4〜1.7:1、最も好ましくは1:3〜1.2:1である。油脂が多い場合は乳化剤特有の味が抑えられ、乳化剤が多い場合は微細な乳化粒子を得ることができる。
(Ratio of oil and fat to emulsifier)
In order to obtain a small emulsified particle size in the present invention, the mass ratio of the fat (D) and the emulsifier (C) is important, and is preferably 1: 6 to 3: 1, more preferably 1: 4 to 1.7. : 1, most preferably 1: 3 to 1.2: 1. When there are many fats and oils, the taste peculiar to an emulsifier is suppressed, and when there are many emulsifiers, fine emulsified particles can be obtained.

食物繊維(E)をさらに配合する場合には、その配合量としては0.1質量%〜5質量%が好ましく、より好ましくは0.5質量%〜3質量%であり、最も好ましくは0.5質量%〜2質量%である。0.1質量%より少ないと食物繊維のもつ生理効果が得られず、5質量%より多いと、臨床学的には食物繊維のもつ生理副作用が発現しやすくなる。   When dietary fiber (E) is further blended, the blending amount is preferably 0.1% by mass to 5% by mass, more preferably 0.5% by mass to 3% by mass, and most preferably 0.8%. It is 5 mass%-2 mass%. If the amount is less than 0.1% by mass, the physiological effect of dietary fiber cannot be obtained. If the amount is more than 5% by mass, physiological side effects of dietary fiber are likely to occur clinically.

本発明の栄養組成物は、蛋白質(A)の配合量が2〜11質量%、糖質(B)の配合量が10〜35質量%、乳化剤(C)と油脂(D)の配合量の合計が1〜13質量%含有するものである。さらに食物繊維(E)を含む場合は、食物繊維(E)0.1〜5質量%を含有するものである。   The nutritional composition of the present invention has a protein (A) content of 2 to 11% by mass, a carbohydrate (B) content of 10 to 35% by mass, an emulsifier (C) and a fat (D). The total content is 1 to 13% by mass. Furthermore, when dietary fiber (E) is included, 0.1-5 mass% of dietary fiber (E) is contained.

(その他の原材料)
本発明の栄養組成物は、上記の必須成分以外に、ミネラル、ビタミン、酸味料、高甘味度甘味料、果汁、香料、色素を使用してもよい。
(Other raw materials)
In addition to the above essential components, the nutritional composition of the present invention may use minerals, vitamins, acidulants, high-intensity sweeteners, fruit juices, flavors, and pigments.

(ミネラル)
本発明の栄養組成物は、ナトリウム、カリウム、カルシウム、マグネシウム、鉄、亜鉛、銅、セレン、クロム、モリブデン、マンガン、ヨウ素などのミネラルを含むことができる。ナトリウム、カリウム、カルシウム、マグネシウムの提供源は、塩化物、水酸化物、リン酸塩、縮合リン酸塩、硫酸塩、炭酸塩、及び有機酸塩などが挙げられるが、本発明のpH範囲において水溶性であることが望ましい。これらのミネラル供給源が難溶性もしくは不溶性の場合はミネラルの沈降物を発生しやすくなり、分散剤などで液中に分散させた場合でも安定性の低下が起こり好ましくない。鉄はクエン酸第一鉄Naやピロリン酸第二鉄、亜鉛や銅はグルコン酸塩、また、鉄、亜鉛、銅、セレン、クロム、モリブデン、マンガン、及びヨウ素は、酵母由来のものが用いられる。
(mineral)
The nutritional composition of the present invention can contain minerals such as sodium, potassium, calcium, magnesium, iron, zinc, copper, selenium, chromium, molybdenum, manganese, iodine and the like. Sources of sodium, potassium, calcium and magnesium include chlorides, hydroxides, phosphates, condensed phosphates, sulfates, carbonates, and organic acid salts, but in the pH range of the present invention. It is desirable to be water-soluble. When these mineral sources are hardly soluble or insoluble, mineral precipitates are likely to be generated, and even when dispersed in a liquid with a dispersant or the like, stability is lowered, which is not preferable. Iron is ferrous citrate Na and ferric pyrophosphate, zinc and copper are gluconates, and iron, zinc, copper, selenium, chromium, molybdenum, manganese, and iodine are derived from yeast .

(ビタミン)
本発明の栄養組成物は、ビタミンA、ビタミンD、ビタミンE、ビタミンK、ビタミンB1、ビタミンB2、ビタミンB6、ナイアシン、パントテン酸Ca、葉酸、ビタミンB12、ビタミンC、及びビオチンなどのビタミンを含むことができる。
(vitamin)
The nutritional composition of the present invention contains vitamins such as vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B6, niacin, pantothenic acid Ca, folic acid, vitamin B12, vitamin C, and biotin. be able to.

(酸性成分)
本発明においては、液状栄養組成物を予め酸性としておくために酸性成分を用いることができる。食品で用いられる種々の酸性成分として、リン酸、塩酸、硫酸、クエン酸、リンゴ酸、酒石酸、コハク酸、フマル酸、乳酸などがある。所望のpHとした場合の浸透圧や、製造上の取扱いの安全性を加味すると、クエン酸、酒石酸、フマル酸が好ましい。なお、本発明の栄養組成物は、ペプチド、アミノ酸、糖質、ミネラル、及びビタミンなど通常の飲料よりも非常に多い原材料の種類と量を配合するため、pH緩衝作用が顕著に強く、多量の酸性成分を添加する必要がある。
(Acidic component)
In the present invention, an acidic component can be used to make the liquid nutritional composition acidic in advance. Examples of various acidic components used in food include phosphoric acid, hydrochloric acid, sulfuric acid, citric acid, malic acid, tartaric acid, succinic acid, fumaric acid, and lactic acid. Citric acid, tartaric acid, and fumaric acid are preferable in consideration of the osmotic pressure when the pH is set to a desired value and safety in handling in production. In addition, the nutritional composition of the present invention contains significantly more kinds and amounts of raw materials such as peptides, amino acids, sugars, minerals, and vitamins than ordinary beverages, and therefore has a significantly strong pH buffering action, and a large amount It is necessary to add an acidic component.

(pH)
本発明において静菌性を目的として液状栄養組成物を予め酸性とする場合は、pH2.0〜5.0である。pH2.0より小さくするには非常に多くの量の酸性成分が必要となり過剰品質となる。pH5.0より大きいと静菌性の効果が得られなくなる。pH4.6以下であると殺菌条件を緩和することが可能であり、含有成分の栄養組成物の防止及び殺菌コストの低減などによる経済上のメリットが得られることから、pH3.0〜4.6とすることが好ましい。
(PH)
In the present invention, when the liquid nutritional composition is previously acidified for the purpose of bacteriostatic properties, the pH is 2.0 to 5.0. To make the pH lower than 2.0, a very large amount of acidic component is required, resulting in excessive quality. If the pH is higher than 5.0, the bacteriostatic effect cannot be obtained. Since the sterilization conditions can be relaxed when the pH is 4.6 or less, and economical advantages are obtained by preventing the nutritional composition of the components and reducing the sterilization cost, the pH is 3.0 to 4.6. It is preferable that

(高甘味度甘味料)
本発明の栄養組成物は、糖質として甘味度が15〜30程度の澱粉分解物が好ましいことから、全体の甘味が少なくなりやすい。高甘味度甘味料で甘味を補うことができる。高甘味度甘味料として、例えば、ネオテーム、スクラロース、アセスルファムカリウム、ステビア、及びソーマチンが好ましいものとして挙げられる。さらに本発明に特有のペプチドやアミノ酸やビタミン及びミネラルからくる総合的な苦味やえぐ味のマスキングを目的とすると、ネオテーム、スクラロース、ステビア、及びソーマチンが好ましく、中でもネオテーム及びクラロースが最も好ましい。一方、高甘味度甘味料であるアスパルテームは熱や酸に弱いため好ましくない。
(High intensity sweetener)
The nutritional composition of the present invention is preferably a starch degradation product having a sweetness level of about 15 to 30 as a saccharide, and therefore the overall sweetness tends to be reduced. Sweetness can be supplemented with high-intensity sweeteners. Preferred examples of the high-intensity sweetener include neotame, sucralose, acesulfame potassium, stevia and thaumatin. Furthermore, for the purpose of masking the overall bitterness and pungent taste that comes from peptides, amino acids, vitamins and minerals unique to the present invention, neotame, sucralose, stevia and thaumatin are preferred, and neotame and clallose are most preferred. On the other hand, aspartame, which is a high-intensity sweetener, is not preferred because it is vulnerable to heat and acid.

(熱量)
本発明の液状栄養組成物の熱量は流動食1mlあたり1.2kcal以上が好ましく、より好ましくは1.4kcal以上、最も好ましくは1.6kcal以上である。臨床栄養的には、単位体積あたりの熱量を多くすることは、投与時間の短縮だけでなく、肺炎の原因として問題となっている胃食道逆流を誘発する胃への容量負荷が少ない利点がある。更には、単位容積あたりに含まれる水が少ないため、摂取水分を制限する必要がある患者にも利便性が高いなど、付加価値の高い流動食として評価されている。
(Calorie)
The amount of heat of the liquid nutritional composition of the present invention is preferably 1.2 kcal or more per ml of liquid food, more preferably 1.4 kcal or more, and most preferably 1.6 kcal or more. In clinical nutrition, increasing the amount of heat per unit volume not only shortens the administration time, but also has the advantage of reducing the capacity load on the stomach that induces gastroesophageal reflux, which is a cause of pneumonia . Furthermore, since the amount of water contained per unit volume is small, it is evaluated as a liquid food with high added value, such as high convenience for patients who need to limit the amount of water intake.

(製造方法の概要)
本発明の栄養組成物は、調合工程、均質化工程、充填工程、及び殺菌工程を行うことにより製造することができる。
(Outline of manufacturing method)
The nutritional composition of the present invention can be produced by performing a preparation process, a homogenization process, a filling process, and a sterilization process.

(製造方法・調合工程)
調合工程は水にそれぞれの原材料を溶解する工程であり、タンクの上部から原材料を投入しプロペラ攪拌により溶解させるか、溶けにくい原材料の場合は高速攪拌機もしくはパウブレンダーのような溶解ポンプで溶解させる。ただしモノグリセリドは融点が高いため、事前に油脂に分散させ70℃以上の温度で融解させておく必要がある。それぞれの原材料を溶解する工程の水温は、25℃〜80℃が好ましく、より好ましくは40℃〜75℃、最も好ましくは50〜70℃である。水温が低すぎると原材料が効率的に溶解しないばかりか、そのあとの均質化工程に送液する際に加温工程がない場合には、均質化機で乳化粒子が効率的に微細化されない。また水温が高すぎると原材料は効率的に溶解できるものの、ビタミンや魚油などの熱分解しやすい成分に劣化が起こり、栄養成分などの品質において好ましくない影響がでる。
(Manufacturing method / mixing process)
The blending step is a step of dissolving each raw material in water. The raw material is charged from the upper part of the tank and dissolved by propeller stirring. In the case of a raw material that is difficult to dissolve, the raw material is dissolved by a high-speed stirrer or a dissolution pump such as a powder blender. However, since monoglyceride has a high melting point, it is necessary to disperse it in oil and fat in advance and melt it at a temperature of 70 ° C. or higher. The water temperature in the step of dissolving each raw material is preferably 25 ° C to 80 ° C, more preferably 40 ° C to 75 ° C, and most preferably 50 to 70 ° C. If the water temperature is too low, the raw materials are not efficiently dissolved, and if there is no heating step when the solution is fed to the subsequent homogenization step, the emulsified particles are not efficiently refined by the homogenizer. If the water temperature is too high, the raw materials can be dissolved efficiently, but components that are easily thermally decomposed, such as vitamins and fish oil, are deteriorated, and this has an undesirable effect on the quality of nutritional components.

(製造方法・均質化工程)
均質化工程は乳化粒子の微細化を行うために、高速ホモミキサー、マントンゴーリン式ホモジナイザー(低圧ホモジナイザー、高圧ホモジナイザー)、マイクロフルイダイザーなどが用いられるが、均質化能力や処理流量や製造コストから、高圧ホモジナイザーが好ましく用いられる。均質化圧力は10MPa〜150MPaが好ましく、より好ましくは30MPa〜100MPa、最も好ましくは40MPa〜80MPaである。しかし、均質化圧力を上げるよりも均質化の処理回数を増やす方が、本発明の栄養組成物には有効である。均質化の処理回数は、2回以上が好ましく、より好ましくは3回以上、最も好ましくは4回以上である。
(Manufacturing method / homogenization process)
In the homogenization process, high-speed homomixers, Manton gorin type homogenizers (low pressure homogenizers, high pressure homogenizers), microfluidizers, etc. are used to refine the emulsion particles. From the homogenization capacity, processing flow rate, and production cost, A high pressure homogenizer is preferably used. The homogenization pressure is preferably 10 MPa to 150 MPa, more preferably 30 MPa to 100 MPa, and most preferably 40 MPa to 80 MPa. However, increasing the number of homogenization treatments is more effective for the nutritional composition of the present invention than increasing the homogenization pressure. The number of homogenization treatments is preferably 2 times or more, more preferably 3 times or more, and most preferably 4 times or more.

(製造方法・殺菌工程)
殺菌工程は、ボイル殺菌、レトルト殺菌、及びUHT殺菌などの加熱殺菌が用いられる。pHが4.6以下の場合は90℃15分などのボイル殺菌が用いられ、簡易な装置での殺菌が可能である。しかし、栄養成分の劣化を考慮するとUHT殺菌が好ましい。UHT殺菌には直接方式と間接方式があり、間接方式にはプレート式とチューブラー式がある。直接方式は風味や栄養成分の劣化に対し特に効果を発揮するが、乳化粒子の粗大化が起き乳化安定性が低下するので、UHT殺菌間接方式が最も好ましい。pHが4.6以下の場合はUHT殺菌では、110℃1〜30秒などの殺菌条件が可能であるが、好熱好酸菌を配慮し140℃1〜10秒の処理をすることが好ましい。
(Manufacturing method and sterilization process)
In the sterilization process, heat sterilization such as boil sterilization, retort sterilization, and UHT sterilization is used. When the pH is 4.6 or less, boil sterilization at 90 ° C. for 15 minutes or the like is used, and sterilization with a simple device is possible. However, UHT sterilization is preferable in view of deterioration of nutritional components. There are a direct method and an indirect method for UHT sterilization, and an indirect method includes a plate type and a tubular type. The direct method is particularly effective for flavor and deterioration of nutritional components, but the UHT sterilization indirect method is most preferable because the emulsified particles are coarsened and the emulsion stability is lowered. When pH is 4.6 or less, sterilization conditions such as 110 ° C. for 1 to 30 seconds are possible in UHT sterilization, but it is preferable to perform treatment at 140 ° C. for 1 to 10 seconds in consideration of thermoacidophilic bacteria. .

(製造方法・充填工程)
充填工程は、ボイル殺菌やレトルト殺菌の場合は殺菌前に密封容器に充填し、UHT殺菌の場合は殺菌後に無菌的に密封容器に充填する。密封容器は、ボイル殺菌やレトルト殺菌の場合は、缶やアルミパウチ、及びソフトバッグ容器などの軟包材が挙げられ、UHT殺菌の場合はテトラパックなどが挙げられる。本発明の栄養組成物の酸化を抑制するために、ソフトバッグ容器などの軟包材の場合は、ポリ塩化ビニリデンコートや酸化アルミ(アルミナ)系透明蒸着、及びシリカ系透明蒸着フィルムが好ましい。またテトラパックの場合はストリップテープからの酸素透過があるため、MPMストリップテープよりもMSEストリップテープが好ましい。
(Manufacturing method and filling process)
In the filling process, in the case of boil sterilization or retort sterilization, the sealed container is filled before sterilization, and in the case of UHT sterilization, the sealed container is aseptically filled after sterilization. In the case of boil sterilization or retort sterilization, examples of the sealed container include cans, aluminum pouches, and soft packaging materials such as a soft bag container, and in the case of UHT sterilization, tetrapack and the like. In order to suppress the oxidation of the nutritional composition of the present invention, in the case of a soft packaging material such as a soft bag container, a polyvinylidene chloride coat, an aluminum oxide (alumina) transparent vapor deposition, and a silica transparent vapor deposition film are preferable. In the case of Tetra Pak, since there is oxygen permeation from the strip tape, the MSE strip tape is preferable to the MPM strip tape.

(熱量)
本発明の栄養組成物の熱量は、栄養組成物に含まれる蛋白質、脂質、糖質、食物繊維から算出されるものである。蛋白質、脂質、糖質の算出方法は、Atwaterのエネルギー換算係数を用いた。食物繊維については、厚生労働省の平成15年2月17日付の通知に従って計算した。
(Calorie)
The calorie | heat amount of the nutrition composition of this invention is computed from the protein, lipid, saccharide | sugar, and dietary fiber which are contained in a nutrition composition. For the calculation method of protein, lipid, and carbohydrate, the energy conversion coefficient of Atwater was used. The dietary fiber was calculated according to the notification of February 17, 2003 from the Ministry of Health, Labor and Welfare.

(pH)
本発明の栄養組成物のpHの好ましい範囲は前述したとおりである。この測定は、製造1日後に栄養組成物を20〜30℃に調温し、(株)堀場製作所製pHメーターM−13により測定した。
(PH)
The preferable range of the pH of the nutritional composition of the present invention is as described above. In this measurement, the temperature of the nutritional composition was adjusted to 20 to 30 ° C. one day after production, and measured with a pH meter M-13 manufactured by Horiba, Ltd.

(粘度)
本発明の栄養組成物の粘度は、良好なチューブ流動性とするため低い粘度とすることが好ましく、品温が20℃において15mPa・s以下が好ましく、より好ましくは10mPa・s以下である。本発明の栄養組成物の粘度は、製造1日後にブルックフィールドエンジニアリングラボラトリーズ社製B型粘度計を使用し、ローターBLアダプター・回転数30で測定した。
(viscosity)
The viscosity of the nutritional composition of the present invention is preferably low in order to achieve good tube fluidity, and is preferably 15 mPa · s or less, more preferably 10 mPa · s or less at a product temperature of 20 ° C. The viscosity of the nutritional composition of the present invention was measured using a B-type viscometer manufactured by Brookfield Engineering Laboratories 1 day after production and using a rotor BL adapter and a rotation speed of 30.

(浸透圧)
本発明の栄養組成物の浸透圧は、浸透圧性下痢などを考慮し低い方が好ましい。200mOsm/kg〜1200mOsm/kgが好ましく、より好ましくは200mOsm/kg〜1000mOsm/kgである。本発明の浸透圧の測定は、製造1日後にアドバンスインストロメンツ社製3D3を用いて測定した。
(Osmotic pressure)
The osmotic pressure of the nutritional composition of the present invention is preferably low considering osmotic diarrhea and the like. 200 mOsm / kg to 1200 mOsm / kg is preferable, and 200 mOsm / kg to 1000 mOsm / kg is more preferable. The osmotic pressure of the present invention was measured using Advanced Instruments 3D3 one day after production.

(乳化安定性)
本発明の栄養組成物の乳化安定性は、主に脂質粒子が均一に分散している狭義の乳化を指すが、それだけではなく蛋白質等の凝集がないなど全ての成分が均一に分散している広義の乳化安定性も含む。本発明の乳化安定性の評価は、製造1日後に性状(クリーミングや凝集や沈澱)を目視確認することで評価した。また長期にわたる乳化安定性は、40℃・1ヶ月間の静置保存を行ったあとに性状(クリーミングや凝集や沈澱)を目視確認することで評価した。クリーミングや凝集や沈澱が全くないものは「○」、凝集や沈澱はなくクリーミングはあるが軽く振ると再分散し均一に戻るものは「△」、凝集や沈澱があり軽く振っても再分散せず使用に値しないものは「×」とした。
(Emulsification stability)
The emulsification stability of the nutritional composition of the present invention mainly refers to emulsification in a narrow sense in which lipid particles are uniformly dispersed, but not only that, all components are uniformly dispersed, such as no aggregation of proteins and the like. Including broad emulsion stability. The emulsification stability of the present invention was evaluated by visually confirming the properties (creaming, aggregation and precipitation) one day after production. The long-term emulsification stability was evaluated by visually confirming the properties (creaming, flocculation and precipitation) after standing at 40 ° C. for 1 month. “○” indicates that there is no creaming, aggregation or precipitation, and there is no aggregation or precipitation, but there is creaming. Those not worthy of use were marked with “x”.

(粒径)
本発明の栄養組成物の粒径は、主に脂質粒子が分散した乳化粒子径を指すが、それだけでなく蛋白質等の凝集などによる粒子径も含む。乳化安定性と粒径は明確な関係があることが知られており、粒径が小さいほど乳化安定性に優れ、大きいほど不安定であることは、ストークスの法則によって一般的に知られている(食品コロイド入門(西成勝好監訳)幸書房p93)。乳化安定性から判断すると、1μm以下が好ましく、より好ましくは0.20μm以下、最も好ましくは0.15μm以下である。また、視覚的な透明感の観点から判断しても、乳化安定性と同様小さいほど好ましい。本発明の栄養組成物の粒径は、製造1日後に(株)堀場製作所社製レーザー回折式粒度分布計LA−950を用いて測定した。
(Particle size)
The particle size of the nutritional composition of the present invention mainly refers to an emulsified particle size in which lipid particles are dispersed, but also includes a particle size due to aggregation of proteins and the like. It is known that there is a clear relationship between emulsion stability and particle size. It is generally known from Stokes' law that the smaller the particle size, the better the emulsion stability, and the larger the particle size, the more unstable it is. (Introduction to food colloid (translated by Katsuyoshi Nishinari) Koshobo p93). Judging from the emulsion stability, it is preferably 1 μm or less, more preferably 0.20 μm or less, and most preferably 0.15 μm or less. Moreover, even if it judges from a viewpoint of visual transparency, it is so preferable that it is small like emulsion stability. The particle size of the nutritional composition of the present invention was measured using a laser diffraction particle size distribution analyzer LA-950 manufactured by Horiba, Ltd. 1 day after production.

(総合評価)
総合評価は、以下のようにした。粘度は11〜15mPa・sのものは「△」、15mPa・sより大きいものは「×」とした。浸透圧は1001〜1200mOsm/kgのものは「△」、1200mOsm/kg以上のものは「×」とした。粒径は1μmより大きいものは「×」、0.2〜1μmのものは「△」、乳化安定性は前記のとおりとし、以上の基準において「×」が1つでもあれば総合評価は「×」、「×」が1つもなく「△」が1つでもあれば総合評価は「△」、「×」も「△」もなければ総合評価は「○」とした。
(Comprehensive evaluation)
The overall evaluation was as follows. The viscosity of 11 to 15 mPa · s was “Δ”, and the viscosity of more than 15 mPa · s was “x”. The osmotic pressure was “Δ” for 1001 to 1200 mOsm / kg, and “x” for 1200 mOsm / kg or more. If the particle size is larger than 1 μm, “×”, 0.2-1 μm is “Δ”, and the emulsion stability is as described above. If there is at least one “×” in the above criteria, the overall evaluation is “ If there is no “x” and “x” and there is even one “Δ”, the overall evaluation is “Δ”, and if there is neither “x” nor “Δ”, the overall evaluation is “◯”.

(実施例1−1)
本発明の栄養組成物の代表例を示す。表1および2のように、モノグリセリドであるモノグリセリンステアリン酸エステル0.6質量%、融点−10℃のMCT(構成脂肪酸比;カプリル酸:カプリン酸=8:2)1.7質量%、融点−15℃の精製イワシ油0.1質量%を混合し80℃に加熱し溶融混合した。その後、前記モノグリセリドと油脂との溶融混合物、重量平均分子量5200のコラーゲンペプチド3.0質量%、重量平均分子量2380の大豆ペプチド3.0質量%、L−トリプトファン0.1質量%、L−ロイシン0.2質量%、L−メチオニン0.1質量%、L−ヒスチジン0.1質量%、L−バリン0.1質量%、L−フェニルアラニン0.3質量%、数平均分子量560の澱粉分解物(デキストリン)22.0質量%、デカグリセリンモノオレイン酸エステル1.2質量%、難消化性デキストリン1.0質量%、ヘキサメタリン酸ナトリウム0.1質量%、クエン酸カリウム0.1質量%、塩化カルシウム0.15質量%、硫酸マグネシウム0.25質量%、クエン酸結晶0.55質量%、ブドウ6倍濃縮透明果汁0.5質量%、スクラロース製剤0.05質量%、微量ミネラルミックス0.05質量%、ビタミンミックス0.126質量%、グレープ香料0.1質量%、及びクチナシ赤色素0.1質量%を、総質量2000gとなるように60℃の温水に溶解させた。これを60℃保持のまま、均質化圧70MPaで2回処理した。常温まで冷却したのちに100gずつアルミパウチに密封充填し、90℃15分でボイル殺菌した。
(Example 1-1)
The typical example of the nutrition composition of this invention is shown. As shown in Tables 1 and 2, the monoglyceride monoglycerin stearate 0.6% by mass, the melting point −10 ° C. MCT (constituent fatty acid ratio; caprylic acid: capric acid = 8: 2) 1.7% by mass, the melting point 0.1% by mass of refined sardine oil at −15 ° C. was mixed, heated to 80 ° C. and melt mixed. Thereafter, a molten mixture of the monoglyceride and fat, 3.0% by mass of collagen peptide having a weight average molecular weight of 5200, 3.0% by mass of soybean peptide having a weight average molecular weight of 2380, 0.1% by mass of L-tryptophan, L-leucine 0 .2% by mass, L-methionine 0.1% by mass, L-histidine 0.1% by mass, L-valine 0.1% by mass, L-phenylalanine 0.3% by mass, number average molecular weight 560 starch degradation product ( Dextrin) 22.0 mass%, decaglycerin monooleate 1.2 mass%, indigestible dextrin 1.0 mass%, sodium hexametaphosphate 0.1 mass%, potassium citrate 0.1 mass%, calcium chloride 0.15 mass%, magnesium sulfate 0.25 mass%, citric acid crystals 0.55 mass%, grape 6 times concentrated clear fruit juice 0.5 mass% Sucralose preparation 0.05% by mass, trace mineral mix 0.05% by mass, vitamin mix 0.126% by mass, grape flavor 0.1% by mass, gardenia red pigment 0.1% by mass so that the total mass becomes 2000 g In 60 ° C. warm water. This was treated twice with a homogenization pressure of 70 MPa while maintaining the temperature at 60 ° C. After cooling to room temperature, 100 g each was sealed and filled in an aluminum pouch, and boiled at 90 ° C. for 15 minutes.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

実施例1−1の評価の結果を表3に示す。栄養成分は熱量1.66kcal/ml、蛋白質18エネルギー%、糖質59エネルギー%、油脂22エネルギー%、食物繊維1エネルギー%、アミノ酸スコア100である。また物性評価の結果は、pH4.2、粘度9mPa・s、浸透圧970mOsm/kg、粒径0.13μm、乳化安定性は○、40℃・1ヶ月後の乳化安定性は○で、総合評価として○であった。本発明の特定の組み合わせによれば、高熱量の場合でも優れた乳化安定性を示すと考えられる。   Table 3 shows the results of the evaluation of Example 1-1. Nutritional components are 1.66 kcal / ml calorie, 18 energy% protein, 59 energy% sugar, 22 energy% fat and oil, 1 energy% dietary fiber, and 100 amino acid score. The results of physical property evaluation were as follows: pH 4.2, viscosity 9 mPa · s, osmotic pressure 970 mOsm / kg, particle size 0.13 μm, emulsification stability ○, emulsification stability after 40 ° C. and 1 month ○ As ○. According to the specific combination of the present invention, it is considered that excellent emulsification stability is exhibited even in the case of a high calorific value.

Figure 2014003960
Figure 2014003960

(実施例1−2、比較例1)
実施例1−1の油脂と乳化剤を表1のように変更した以外は、実施例1−1と同様の操作を行った。結果を表3に示す。油脂を融点−10℃のナタネ白絞め油に置き換えた実施例1−2は、実施例1−1と同様の好ましい物性値を示した。一方、乳化剤として(ii)飽和脂肪酸モノグリセリドを含まなかった比較例1は、微細な粒径が得られず、製造1日後の乳化安定性では再分散可能なクリーミングが発生し、40℃1ヶ月後の乳化安定性では再分散しないクリーミングが発生した。このことから、乳化剤(C)として特定の(i)ポリグリセリン脂肪酸エステル及び(ii)飽和脂肪酸モノグリセリドの組み合わすことにより、優れた乳化安定性を示すという結論に至った。
(Example 1-2, Comparative Example 1)
The same operation as in Example 1-1 was performed except that the oil and fat and the emulsifier in Example 1-1 were changed as shown in Table 1. The results are shown in Table 3. Example 1-2 in which the fats and oils were replaced with rapeseed white oil having a melting point of −10 ° C. showed the same preferred physical property values as Example 1-1. On the other hand, Comparative Example 1 containing no (ii) saturated fatty acid monoglyceride as an emulsifier did not obtain a fine particle size, and re-dispersed creaming occurred in the emulsion stability after 1 day of production, after 1 month at 40 ° C. In the emulsion stability, creaming that does not redisperse occurred. From this, it came to the conclusion that the combination of specific (i) polyglycerin fatty acid ester and (ii) saturated fatty acid monoglyceride as emulsifier (C) shows excellent emulsification stability.

(実施例2−1〜実施例2−2、比較例2−1〜比較例2−2)
実施例1−1の重量平均分子量2380の大豆ペプチドを表4のように変更した以外は実施例1−1と同様の操作を行った。結果を表5に示す。重量平均分子量13670の大豆ペプチドを含む比較例2−2は製造1日後に沈澱を生じ、重量平均分子量9415の大豆ペプチドを含む比較例2−1は40℃1ヵ月後に沈澱を生じていた。このことから、コラーゲンペプチド、及び重量平均分子量が1000〜5000の植物性ペプチドを用いれば、乳化安定性が向上するという結論に至った。
(Example 2-1 to Example 2-2, Comparative Example 2-1 to Comparative Example 2-2)
The same operation as in Example 1-1 was performed except that the soybean peptide having a weight average molecular weight of 2380 in Example 1-1 was changed as shown in Table 4. The results are shown in Table 5. Comparative Example 2-2 containing soybean peptide having a weight average molecular weight of 13670 produced precipitation after 1 day of production, and Comparative Example 2-1 containing soybean peptide having a weight average molecular weight of 9415 produced precipitation after 1 month at 40 ° C. From this, it was concluded that the use of a collagen peptide and a vegetable peptide having a weight average molecular weight of 1000 to 5000 improves the emulsion stability.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例3−1〜実施例3−2、比較例3−1〜比較例3−3)
実施例1−1の澱粉分解物を表6のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表7に示す。数平均分子量342の澱粉分解物(麦芽糖)を含む比較例3−3は、浸透圧が1460mOsm/kgと高かった。数平均分子量が1000〜1900の澱粉分解物を含む比較例3−1〜比較例3−2は、乳化粒子の粒径が著しく大きく乳化安定性に劣っていた。このことから、数平均分子量400〜900の澱粉分解物を用いれば、優れた物性値を示すという結論に至った。
(Example 3-1 to Example 3-2, Comparative Example 3-1 to Comparative Example 3-3)
The same operation as in Example 1-1 was performed except that the starch degradation product of Example 1-1 was changed as shown in Table 6. The results are shown in Table 7. In Comparative Example 3-3 including a starch degradation product (malt sugar) having a number average molecular weight of 342, the osmotic pressure was as high as 1460 mOsm / kg. Comparative Example 3-1 to Comparative Example 3-2 containing a starch degradation product having a number average molecular weight of 1000 to 1900 had remarkably large emulsion particle size and poor emulsion stability. From this, it came to the conclusion that if a starch-decomposed product having a number average molecular weight of 400 to 900 is used, an excellent physical property value is exhibited.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例4−1、比較例4−1〜比較例4−11)
実施例1−1のデカグリセリンモノオレイン酸エステルを表8のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表9に示す。構成する脂肪酸が実施例1のオレイン酸以外でもミリスチン酸であれば微細な粒径が得られ乳化安定性も良好であった。構成する脂肪酸がラウリン酸であったり、グリセリンの重合度が5であったりすると、微細な粒径が得られなくなり、製造1日後の乳化安定性も再分散可能なクリーミングが発生し、40℃1ヶ月後の乳化安定性では再分散しないクリーミングが発生した。グリセリン重合度が4以下やステアリン酸とのエステルなどのポリグリセリン脂肪酸エステルや、ポリグリセリン脂肪酸エステル以外の乳化剤は、均質化直後に油水分離を起こしたため物性分析さえも不可能であった。このことから、ポリグリセリンの平均重合度が6〜20であり且つ脂肪酸がオレイン酸又はミリスチン酸であるポリグリセリン脂肪酸エステルを用いれば、乳化安定性が向上するという結論に至った。
(Example 4-1, Comparative example 4-1 to Comparative example 4-11)
The same operation as in Example 1-1 was performed except that the decaglycerin monooleate of Example 1-1 was changed as shown in Table 8. The results are shown in Table 9. If the fatty acid constituting the substance is myristic acid other than the oleic acid of Example 1, a fine particle size was obtained and the emulsion stability was good. When the constituent fatty acid is lauric acid or the polymerization degree of glycerin is 5, a fine particle size cannot be obtained, and the emulsification stability after 1 day of production causes re-dispersion creaming. In the emulsion stability after months, creaming that did not re-disperse occurred. Polyglycerin fatty acid esters such as esters with stearic acid having a degree of glycerin polymerization of 4 or less, and emulsifiers other than polyglycerin fatty acid esters caused oil-water separation immediately after homogenization, and even physical property analysis was impossible. From this, it was concluded that the use of a polyglycerin fatty acid ester having an average degree of polymerization of polyglycerol of 6 to 20 and a fatty acid of oleic acid or myristic acid improves the emulsion stability.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例5−1〜実施例5−2、比較例5−1〜実施例5−2)
実施例1−1のモノグリセリンステアリン酸エステルを表10のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表11に示す。構成する脂肪酸が実施例1のオレイン酸以外でもパルミチン酸やラウリン酸のような飽和脂肪酸であれば微細な粒径が得られ乳化安定性も良好であった。構成する脂肪酸がオレイン酸やリノール酸であると、微細な粒径が得られなくなり、製造1日後の乳化安定性も再分散可能なクリーミングが発生し、40℃1ヵ月後の乳化安定性では再分散しないクリーミングが発生した。このことから、炭素数12〜22の飽和脂肪酸モノグリセリドを用いれば、乳化安定性が向上するという結論に至った。
(Example 5-1 to Example 5-2, Comparative Example 5-1 to Example 5-2)
The same operation as in Example 1-1 was performed except that the monoglycerin stearate ester of Example 1-1 was changed as shown in Table 10. The results are shown in Table 11. If the constituent fatty acid was a saturated fatty acid such as palmitic acid or lauric acid other than the oleic acid of Example 1, a fine particle size was obtained and the emulsion stability was good. When the constituent fatty acid is oleic acid or linoleic acid, a fine particle size cannot be obtained, and the emulsification stability after 1 day of production also causes re-dispersion creaming. Creaming that does not disperse occurred. This led to the conclusion that the use of saturated fatty acid monoglycerides having 12 to 22 carbon atoms improves the emulsion stability.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例6−1〜実施例6−4)
実施例1−1のデカグリセリンオレイン酸エステルとモノグリセリンステアリン酸エステルの総量1.80質量%を一定とし、その比率を表12のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表13に示す。デカグリセリンオレイン酸エステルに対するモノグリセリンステアリン酸エステルの量が2.5以下であれば、製造1日後の乳化安定性も良好であり、1.4以下であれば、微細な粒径が得られ40℃1ヵ月後の乳化安定性までも良好であった。
(Example 6-1 to Example 6-4)
The same operation as in Example 1-1, except that the total amount of decaglycerin oleate and monoglycerin stearate in Example 1-1 was constant at 1.80% by mass and the ratio was changed as shown in Table 12. Went. The results are shown in Table 13. If the amount of monoglycerin stearate to decaglycerin oleate is 2.5 or less, the emulsion stability after 1 day of production is also good, and if it is 1.4 or less, a fine particle size is obtained. The emulsion stability after 1 month at 0 ° C. was also good.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例7−1〜実施例7−6、比較例7−1)
実施例1−1のMCT(C8:C10=8:2)と精製イワシ油の総量1.8質量%を、表14のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表14に示す。融点が50℃である油脂は、粒径がやや大きく、製造1日後の乳化安定性で再分散性はあるもののクリーミングが認められ、40℃1ヵ月後の乳化安定性では再分散しないクリーミングが発生した。融点−30℃以上45℃以下である油脂であれば、比較的小さな粒径が得られ40℃1ヵ月後の乳化安定性までも良好であった。特に、融点が10℃以下である油脂であれば、微細な粒径が得られ、40℃1ヵ月後の乳化安定性までも良好であった。
(Example 7-1 to Example 7-6, Comparative Example 7-1)
The same procedure as in Example 1-1 was performed, except that the total amount of MCT (C8: C10 = 8: 2) and refined sardine oil of Example 1-1 was changed as shown in Table 14. It was. The results are shown in Table 14. Fats and oils with a melting point of 50 ° C have a slightly larger particle size, and although emulsification stability after one day of production is redispersible, creaming is observed, but with emulsification stability after 40 ° C for one month, creaming that does not redisperse occurs. did. If it was fats and oils whose melting | fusing point was -30 degreeC or more and 45 degrees C or less, a comparatively small particle size was obtained and the emulsification stability after 40 degreeC 1 month was also favorable. In particular, if the oil and fat has a melting point of 10 ° C. or less, a fine particle size was obtained, and the emulsion stability after 1 month at 40 ° C. was also good.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例8−1〜7)
実施例1−1のMCT(構成脂肪酸比;カプリル酸:カプリン酸=8:2)と精製イワシ油の総量1.8質量%を全てMCTに置き換え、MCT1.8質量%に対する乳化剤の質量比率を表16のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表17に示す。油脂:乳化剤の質量比率が1:3〜1.5:1で、粘度や浸透圧も充分低く、微細な粒径が得られ40℃1ヵ月後の乳化安定性までも良好であった。
(Examples 8-1 to 7)
MCT (component fatty acid ratio; caprylic acid: capric acid = 8: 2) of Example 1-1 and the total amount of purified sardine oil of 1.8% by mass were all replaced with MCT, and the mass ratio of the emulsifier to 1.8% by mass of MCT Except having changed as shown in Table 16, the same operation as in Example 1-1 was performed. The results are shown in Table 17. The mass ratio of oil and fat: emulsifier was 1: 3 to 1.5: 1, the viscosity and osmotic pressure were sufficiently low, a fine particle size was obtained, and the emulsion stability after 1 month at 40 ° C. was also good.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例9−1〜実施例9−6)
実施例1−1の難消化性デキストリンを表18のように変更した以外は、実施例1−1と同様の操作を行った。その結果を表19に示す。いずれも微細な乳化粒子が得られ、グァーガム分解物以外では製造1日後の乳化安定性も良好であった。実施例9−2および3の製造1日後の乳化安定性で認められたクリーミングは量として非常に多いものだったが、軽度な攪拌で再分散し、使用に値しないレベルには達しなかった。
(Example 9-1 to Example 9-6)
The same operation as in Example 1-1 was performed except that the indigestible dextrin of Example 1-1 was changed as shown in Table 18. The results are shown in Table 19. In any case, fine emulsified particles were obtained, and the emulsion stability after 1 day of production was good except for the guar gum decomposition product. The creaming observed in the emulsion stability one day after the manufacture of Examples 9-2 and 3 was very large in quantity, but was redispersed with mild agitation and did not reach a level unusable.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

(実施例10)
実施例1−1と同じ配合率で総質量を2000kgとなるように60℃の温水に溶解した。これを60℃保持のまま、均質化圧45MPaで2回処理した。そして一旦10℃まで冷却したあと、UHT殺菌間接方式(チューブラー式)にて142℃2秒で殺菌を行い、その後に更に均質圧25MPaで1回処理し、無菌的に125mlのテトラパックに充填した(表20)。その結果は表21のように、実施例1−1とほぼ同じ品質が得られた。
(Example 10)
It melt | dissolved in the hot water of 60 degreeC so that the total mass might be set to 2000 kg with the same compounding rate as Example 1-1. This was treated twice at a homogenization pressure of 45 MPa while maintaining at 60 ° C. Then, after cooling to 10 ° C, sterilization is performed at 142 ° C for 2 seconds using the UHT sterilization indirect method (tubular method), then further processed once at a homogeneous pressure of 25 MPa, and aseptically filled in a 125 ml tetrapack. (Table 20). As a result, as shown in Table 21, almost the same quality as Example 1-1 was obtained.

Figure 2014003960
Figure 2014003960

Figure 2014003960
Figure 2014003960

Claims (9)

蛋白質、糖質、乳化剤、油脂、及び水を含む液状栄養組成物であって、
蛋白質(A)の配合量が2〜11質量%、糖質(B)の配合量が10〜35質量%、乳化剤(C)及び油脂(D)の配合量の合計が1〜13質量%であり、
蛋白質(A)として、コラーゲンペプチド、及び重量平均分子量が1000〜5000の植物性ペプチドを少なくとも含有し、
糖質(B)として、数平均分子量が400〜900である澱粉分解物を少なくとも含有し、
乳化剤(C)として、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル並びに(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドを少なくとも含有し、
油脂(D)として、融点が−30℃〜45℃である油脂を少なくとも含有し、
pHが2.0〜5.0である液状栄養組成物。
A liquid nutritional composition comprising protein, sugar, emulsifier, fat and water, and water,
The amount of protein (A) is 2 to 11% by mass, the amount of carbohydrate (B) is 10 to 35% by mass, and the total amount of emulsifier (C) and fat (D) is 1 to 13% by mass. Yes,
The protein (A) contains at least a collagen peptide and a vegetable peptide having a weight average molecular weight of 1000 to 5000,
As a carbohydrate (B), it contains at least a starch degradation product having a number average molecular weight of 400 to 900,
As the emulsifier (C), (i) a polyglycerol fatty acid ester having an average degree of polymerization of polyglycerol of 6 to 20 and a main fatty acid of oleic acid and / or myristic acid, and (ii) a main fatty acid having 12 to 22 carbon atoms. Containing at least monoglyceride which is a saturated fatty acid of
As fats and oils (D), it contains at least fats and oils having a melting point of -30 ° C to 45 ° C,
A liquid nutritional composition having a pH of 2.0 to 5.0.
前記乳化剤(C)において、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステルと、(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドとの含有比率が、1:0.1〜1:2.5である、請求項1に記載の液状栄養組成物。   In the emulsifier (C), (i) an average degree of polymerization of polyglycerol is 6 to 20 and a main fatty acid is oleic acid and / or myristic acid, and (ii) a main fatty acid has 12 carbon atoms. The liquid nutrition composition of Claim 1 whose content ratio with the monoglyceride which is a saturated fatty acid of -22 is 1: 0.1-1: 2.5. コラーゲンペプチド及び重量平均分子量が1000〜5000の植物性ペプチドを蛋白質(A)全体の50質量%以上、数平均分子量が400〜900の澱粉分解物を糖質(B)全体の50質量%以上、(i)ポリグリセリンの平均重合度が6〜20であり且つ主たる脂肪酸がオレイン酸及び/又はミリスチン酸であるポリグリセリン脂肪酸エステル並びに(ii)主たる脂肪酸が炭素数12〜22の飽和脂肪酸であるモノグリセリドを乳化剤(C)全体の70質量%以上、融点が−30℃〜45℃である油脂を油脂(D)全体の70質量%以上含む、請求項1又は2に記載の液状栄養組成物。   Collagen peptide and plant peptide having a weight average molecular weight of 1000 to 5000 are 50% by mass or more of the whole protein (A), and starch degradation product having a number average molecular weight of 400 to 900 is 50% by mass or more of the whole carbohydrate (B), (I) polyglycerin fatty acid ester in which the average degree of polymerization of polyglycerin is 6 to 20 and the main fatty acid is oleic acid and / or myristic acid; and (ii) monoglyceride in which the main fatty acid is a saturated fatty acid having 12 to 22 carbon atoms. The liquid nutrition composition of Claim 1 or 2 which contains 70 mass% or more of fats and oils (D) of the fats and oils whose melting | fusing point is -30 degreeC-45 degreeC more than 70 mass% of the whole emulsifier (C). 油脂(D)と乳化剤(C)との質量比率が1:6〜3:1である、請求項1〜3のいずれか一項に記載の液状栄養組成物。 Liquid nutrition composition as described in any one of Claims 1-3 whose mass ratio of fats and oils (D) and an emulsifier (C) is 1: 6-3: 1. 融点が−30℃〜45℃である油脂として中鎖脂肪酸トリグリセリドを含有することを特徴とする、請求項1〜4のいずれか一項に記載の液状栄養組成物。   The liquid nutritional composition according to any one of claims 1 to 4, comprising a medium-chain fatty acid triglyceride as an oil having a melting point of -30 ° C to 45 ° C. 蛋白質(A)が、コラーゲンペプチド、重量平均分子量が1000〜5000の植物性ペプチド、及びアミノ酸からなる、請求項1〜5のいずれか一項に記載の液状栄養組成物。   The liquid nutritional composition according to any one of claims 1 to 5, wherein the protein (A) comprises a collagen peptide, a vegetable peptide having a weight average molecular weight of 1000 to 5000, and an amino acid. コラーゲンペプチドの重量平均分子量が2000〜50000である、請求項1〜6のいずれか一項に記載の液状栄養組成物。   The liquid nutrition composition according to any one of claims 1 to 6, wherein the collagen peptide has a weight average molecular weight of 2000 to 50000. さらに食物繊維(E)を0.1質量%〜5質量%含有し、
当該食物繊維(E)が、難消化性デキストリン、イヌリン、及びポリデキストロースからなる群より選ばれる、1種又は2種以上である、請求項1〜7のいずれか一項に記載の液状栄養組成物。
Furthermore, it contains 0.1 mass% to 5 mass% of dietary fiber (E),
The liquid nutrition composition according to any one of claims 1 to 7, wherein the dietary fiber (E) is one or more selected from the group consisting of indigestible dextrin, inulin, and polydextrose. object.
植物性ペプチドが大豆ペプチドである、請求項1〜8のいずれか一項に記載の液状栄養組成物。   The liquid nutrition composition according to any one of claims 1 to 8, wherein the vegetable peptide is a soybean peptide.
JP2012143928A 2012-06-27 2012-06-27 Liquid nutrition composition Active JP6098047B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2012143928A JP6098047B2 (en) 2012-06-27 2012-06-27 Liquid nutrition composition
CN201310253523.2A CN103504293B (en) 2012-06-27 2013-06-24 Liquid nutritional composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012143928A JP6098047B2 (en) 2012-06-27 2012-06-27 Liquid nutrition composition

Publications (2)

Publication Number Publication Date
JP2014003960A true JP2014003960A (en) 2014-01-16
JP6098047B2 JP6098047B2 (en) 2017-03-22

Family

ID=49888149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012143928A Active JP6098047B2 (en) 2012-06-27 2012-06-27 Liquid nutrition composition

Country Status (2)

Country Link
JP (1) JP6098047B2 (en)
CN (1) CN103504293B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016003219A (en) * 2014-06-19 2016-01-12 日油株式会社 Gelatinous nutritive composition
JP2016002060A (en) * 2014-06-19 2016-01-12 日油株式会社 Gelatinous nutritive composition
JP2016116513A (en) * 2014-12-19 2016-06-30 ハウス食品株式会社 Bitterness reducing agent of leucine, and method for reducing bitterness of leucine
WO2018179952A1 (en) * 2017-03-30 2018-10-04 テルモ株式会社 High-calorie nutritional composition, and package
WO2018179953A1 (en) * 2017-03-30 2018-10-04 テルモ株式会社 High-calorie nutritional composition, and package
WO2019017005A1 (en) * 2017-07-21 2019-01-24 テルモ株式会社 High-calorie nutritional composition and package
WO2019017006A1 (en) * 2017-07-21 2019-01-24 テルモ株式会社 High-calorie nutritional composition and package
JP2019182871A (en) * 2019-06-26 2019-10-24 株式会社東洋新薬 Blood triglyceride elevation-inhibiting composition
JP2020025469A (en) * 2018-08-09 2020-02-20 日油株式会社 Beverage
JP2020156435A (en) * 2019-03-28 2020-10-01 テルモ株式会社 Liquid nutrient supplement composition
JP2021003028A (en) * 2019-06-26 2021-01-14 森永製菓株式会社 Food composition, food and drink, supplement, and agent
CN113697210A (en) * 2021-08-18 2021-11-26 德化县祥山大果油茶有限公司 Organic camellia oil oral liquid and preparation method thereof
JPWO2022211013A1 (en) * 2021-03-31 2022-10-06
WO2023282316A1 (en) * 2021-07-08 2023-01-12 株式会社大塚製薬工場 Enteral nutrient preparation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5881784B2 (en) * 2014-07-17 2016-03-09 日清オイリオグループ株式会社 Gel emulsion food
CN104187711B (en) * 2014-07-30 2016-08-17 广东省农业科学院蚕业与农产品加工研究所 A kind of whole albumen and small peptide compound clinical patient spy's meals nutrition emulsion and preparation method thereof
JP7218987B2 (en) * 2016-08-08 2023-02-07 株式会社明治 Acidic liquid nutritional composition
JP2021003006A (en) * 2019-06-25 2021-01-14 テルモ株式会社 High-caloric nutritional composition
JP2021052749A (en) * 2019-09-27 2021-04-08 理研ビタミン株式会社 Milk ingredient-containing beverage
CN115633727B (en) * 2022-09-09 2024-07-12 黑龙江飞鹤乳业有限公司 Process for preparing hydrolyzed protein composition

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61135572A (en) * 1984-12-07 1986-06-23 Nippon Oil & Fats Co Ltd Fat emulsion for intestinal use
JPS6322166A (en) * 1986-04-21 1988-01-29 ノボ ノルディスク アクティーゼルスカブ Nutritious product for intestinal administration
JPS6434271A (en) * 1987-07-31 1989-02-03 Snow Brand Milk Products Co Ltd Liquid nutrient agent having high stability
JPH03117472A (en) * 1989-09-29 1991-05-20 Nippon Oil & Fats Co Ltd Administration bag type fluid diet
JPH0723737A (en) * 1993-07-06 1995-01-27 Nippon Oil & Fats Co Ltd Composition for liquid food and drink and its production
JP2001000144A (en) * 1999-06-17 2001-01-09 Asahi Chem Ind Co Ltd Gel-like highly nutritionally auxiliary food
JP2001245633A (en) * 2000-03-06 2001-09-11 Nof Corp Concentrated liquid food packaged in soft bag
US20010043958A1 (en) * 1998-05-01 2001-11-22 Mcewen John W. Elemental enteral nutritional product
JP2007126379A (en) * 2005-11-02 2007-05-24 Yaizu Suisankagaku Industry Co Ltd Method for producing acidic liquid enteral nutritive preparation
JP2008247848A (en) * 2007-03-30 2008-10-16 Terumo Corp Whey peptide-containing liquid nutritive composition
JP2009011312A (en) * 2007-06-06 2009-01-22 Fuji Oil Co Ltd Gel-like food
WO2012043688A1 (en) * 2010-09-30 2012-04-05 テルモ株式会社 Enteral nutrient
WO2012081982A2 (en) * 2010-12-17 2012-06-21 N.V. Nutricia Whey protein composition with a reduced astringency

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822645B1 (en) * 2001-03-30 2005-03-11 Roquette Freres COMPOSITION FOR ENTERAL NUTRITION COMPRISING FIBERS
CN100375602C (en) * 2002-09-25 2008-03-19 大塚制药株式会社 Gel-form composition for supplying protein and calcium
CA2562947A1 (en) * 2004-03-31 2005-10-13 Meiji Dairies Corporation Antibacterial composition comprising cheese and low ph
KR101397863B1 (en) * 2007-03-30 2014-05-20 가부시키가이샤 메이지 Liquid nutritional composition containing sodium at high concentration and method of producing the same
EP2409575B1 (en) * 2008-10-17 2017-02-22 Nestec S.A. Method for making whey protein compositions

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61135572A (en) * 1984-12-07 1986-06-23 Nippon Oil & Fats Co Ltd Fat emulsion for intestinal use
JPS6322166A (en) * 1986-04-21 1988-01-29 ノボ ノルディスク アクティーゼルスカブ Nutritious product for intestinal administration
JPS6434271A (en) * 1987-07-31 1989-02-03 Snow Brand Milk Products Co Ltd Liquid nutrient agent having high stability
JPH03117472A (en) * 1989-09-29 1991-05-20 Nippon Oil & Fats Co Ltd Administration bag type fluid diet
JPH0723737A (en) * 1993-07-06 1995-01-27 Nippon Oil & Fats Co Ltd Composition for liquid food and drink and its production
US20010043958A1 (en) * 1998-05-01 2001-11-22 Mcewen John W. Elemental enteral nutritional product
JP2001000144A (en) * 1999-06-17 2001-01-09 Asahi Chem Ind Co Ltd Gel-like highly nutritionally auxiliary food
JP2001245633A (en) * 2000-03-06 2001-09-11 Nof Corp Concentrated liquid food packaged in soft bag
JP2007126379A (en) * 2005-11-02 2007-05-24 Yaizu Suisankagaku Industry Co Ltd Method for producing acidic liquid enteral nutritive preparation
JP2008247848A (en) * 2007-03-30 2008-10-16 Terumo Corp Whey peptide-containing liquid nutritive composition
JP2009011312A (en) * 2007-06-06 2009-01-22 Fuji Oil Co Ltd Gel-like food
WO2012043688A1 (en) * 2010-09-30 2012-04-05 テルモ株式会社 Enteral nutrient
WO2012081982A2 (en) * 2010-12-17 2012-06-21 N.V. Nutricia Whey protein composition with a reduced astringency

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016002060A (en) * 2014-06-19 2016-01-12 日油株式会社 Gelatinous nutritive composition
JP2016003219A (en) * 2014-06-19 2016-01-12 日油株式会社 Gelatinous nutritive composition
JP2016116513A (en) * 2014-12-19 2016-06-30 ハウス食品株式会社 Bitterness reducing agent of leucine, and method for reducing bitterness of leucine
JPWO2018179953A1 (en) * 2017-03-30 2020-02-06 テルモ株式会社 High calorie nutrition composition and package
WO2018179952A1 (en) * 2017-03-30 2018-10-04 テルモ株式会社 High-calorie nutritional composition, and package
WO2018179953A1 (en) * 2017-03-30 2018-10-04 テルモ株式会社 High-calorie nutritional composition, and package
JP7116044B2 (en) 2017-03-30 2022-08-09 テルモ株式会社 High calorie nutritional composition and package
JP7116043B2 (en) 2017-03-30 2022-08-09 テルモ株式会社 High calorie nutritional composition and package
JPWO2018179952A1 (en) * 2017-03-30 2020-02-06 テルモ株式会社 High calorie nutrition composition and package
JPWO2019017005A1 (en) * 2017-07-21 2020-08-06 テルモ株式会社 High calorie nutritional composition and package
JP7084926B2 (en) 2017-07-21 2022-06-15 テルモ株式会社 High calorie nutritional composition and packaging
CN110944659A (en) * 2017-07-21 2020-03-31 泰尔茂株式会社 High calorie nutritional composition and package
JPWO2019017006A1 (en) * 2017-07-21 2020-08-20 テルモ株式会社 High calorie nutritional composition and package
WO2019017005A1 (en) * 2017-07-21 2019-01-24 テルモ株式会社 High-calorie nutritional composition and package
WO2019017006A1 (en) * 2017-07-21 2019-01-24 テルモ株式会社 High-calorie nutritional composition and package
JP7084925B2 (en) 2017-07-21 2022-06-15 テルモ株式会社 High calorie nutritional composition and packaging
JP7131191B2 (en) 2018-08-09 2022-09-06 日油株式会社 beverage
JP2020025469A (en) * 2018-08-09 2020-02-20 日油株式会社 Beverage
JP2020156435A (en) * 2019-03-28 2020-10-01 テルモ株式会社 Liquid nutrient supplement composition
JP7176991B2 (en) 2019-03-28 2022-11-22 テルモ株式会社 liquid nutritional composition
JP2021003028A (en) * 2019-06-26 2021-01-14 森永製菓株式会社 Food composition, food and drink, supplement, and agent
JP2019182871A (en) * 2019-06-26 2019-10-24 株式会社東洋新薬 Blood triglyceride elevation-inhibiting composition
JPWO2022211013A1 (en) * 2021-03-31 2022-10-06
JP7332074B2 (en) 2021-03-31 2023-08-23 不二製油株式会社 LIQUID FOOD CONTAINING VEGETABLE PROTEIN AND METHOD FOR PRODUCING SAME
WO2023282316A1 (en) * 2021-07-08 2023-01-12 株式会社大塚製薬工場 Enteral nutrient preparation
CN113697210A (en) * 2021-08-18 2021-11-26 德化县祥山大果油茶有限公司 Organic camellia oil oral liquid and preparation method thereof

Also Published As

Publication number Publication date
CN103504293A (en) 2014-01-15
CN103504293B (en) 2017-08-04
JP6098047B2 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
JP6098047B2 (en) Liquid nutrition composition
JP5779348B2 (en) Acidic liquid nutritional composition
JP5274889B2 (en) Gel acidic concentrated liquid food or nutrient for tube administration
JP5632112B2 (en) Semi-solidified nutrient
JP7084926B2 (en) High calorie nutritional composition and packaging
JP7165583B2 (en) High Calorie, High Protein Nutritional Formula with Collagen
JP5902815B2 (en) Acid liquid nutrient
JP5421769B2 (en) Liquid nutrition composition containing sodium in high concentration and method for producing the same
TWI434659B (en) Induced viscosity nutritional emulsions comprising a carbohydrate-surfactant complex
WO2015146460A1 (en) Liquid nutritional composition
JP6084092B2 (en) Thorough nutritional composition
JP5789981B2 (en) Liquid nutrition composition
JPWO2019017016A1 (en) Package
JP6083962B2 (en) Acid-resistant liquid nutritional composition
CN112120221A (en) High calorie nutritional composition
JP6347954B2 (en) Thorough nutritional composition
WO2018179953A1 (en) High-calorie nutritional composition, and package
WO2013132670A1 (en) Semi-solidified nutritive agent
JP7084925B2 (en) High calorie nutritional composition and packaging
WO2015146461A1 (en) Soybean-protein-containing thick nutritional composition
WO2018179955A1 (en) Package
JP5632113B2 (en) Semisolid nutrient for gastrostoma
JP2020200046A (en) Package
WO2018179952A1 (en) High-calorie nutritional composition, and package

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150602

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161212

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170206

R150 Certificate of patent or registration of utility model

Ref document number: 6098047

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250